US20070207569A1 - Biocompatible bonding method and electronics package suitable for implantation - Google Patents

Biocompatible bonding method and electronics package suitable for implantation Download PDF

Info

Publication number
US20070207569A1
US20070207569A1 US11/517,859 US51785906A US2007207569A1 US 20070207569 A1 US20070207569 A1 US 20070207569A1 US 51785906 A US51785906 A US 51785906A US 2007207569 A1 US2007207569 A1 US 2007207569A1
Authority
US
United States
Prior art keywords
substrate
adhesive
conductive adhesive
flexible assembly
platinum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US11/517,859
Other versions
US7645262B2 (en
Inventor
Robert J. Greenberg
Jerry Ok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vivani Medical Inc
Cortigent Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/174,349 external-priority patent/US7211103B2/en
Priority claimed from US10/236,396 external-priority patent/US7142909B2/en
Priority to US11/517,859 priority Critical patent/US7645262B2/en
Application filed by Individual filed Critical Individual
Assigned to SECOND SIGHT MEDICAL PRODUCTS, INC. reassignment SECOND SIGHT MEDICAL PRODUCTS, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: SECOND SIGHT, LLC
Priority to PCT/US2007/004741 priority patent/WO2007106318A2/en
Publication of US20070207569A1 publication Critical patent/US20070207569A1/en
Priority to US11/928,515 priority patent/US7835794B2/en
Publication of US7645262B2 publication Critical patent/US7645262B2/en
Application granted granted Critical
Priority to US12/899,451 priority patent/US8165680B2/en
Priority to US13/429,215 priority patent/US8285380B2/en
Priority to US13/610,653 priority patent/US8644937B2/en
Assigned to CORTIGENT, INC. reassignment CORTIGENT, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VIVANI MEDICAL, INC.
Adjusted expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0543Retinal electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36046Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of the eye
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L23/00Details of semiconductor or other solid state devices
    • H01L23/02Containers; Seals
    • H01L23/04Containers; Seals characterised by the shape of the container or parts, e.g. caps, walls
    • H01L23/053Containers; Seals characterised by the shape of the container or parts, e.g. caps, walls the container being a hollow construction and having an insulating or insulated base as a mounting for the semiconductor body
    • H01L23/057Containers; Seals characterised by the shape of the container or parts, e.g. caps, walls the container being a hollow construction and having an insulating or insulated base as a mounting for the semiconductor body the leads being parallel to the base
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L23/00Details of semiconductor or other solid state devices
    • H01L23/02Containers; Seals
    • H01L23/10Containers; Seals characterised by the material or arrangement of seals between parts, e.g. between cap and base of the container or between leads and walls of the container
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L23/00Details of semiconductor or other solid state devices
    • H01L23/48Arrangements for conducting electric current to or from the solid state body in operation, e.g. leads, terminal arrangements ; Selection of materials therefor
    • H01L23/488Arrangements for conducting electric current to or from the solid state body in operation, e.g. leads, terminal arrangements ; Selection of materials therefor consisting of soldered or bonded constructions
    • H01L23/498Leads, i.e. metallisations or lead-frames on insulating substrates, e.g. chip carriers
    • H01L23/4985Flexible insulating substrates
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00Apparatus or processes for manufacturing printed circuits
    • H05K3/36Assembling printed circuits with other printed circuits
    • H05K3/361Assembling flexible printed circuits with other printed circuits
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00Apparatus or processes for manufacturing printed circuits
    • H05K3/46Manufacturing multilayer circuits
    • H05K3/4688Composite multilayer circuits, i.e. comprising insulating layers having different properties
    • H05K3/4691Rigid-flexible multilayer circuits comprising rigid and flexible layers, e.g. having in the bending regions only flexible layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/3752Details of casing-lead connections
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2224/00Indexing scheme for arrangements for connecting or disconnecting semiconductor or solid-state bodies and methods related thereto as covered by H01L24/00
    • H01L2224/01Means for bonding being attached to, or being formed on, the surface to be connected, e.g. chip-to-package, die-attach, "first-level" interconnects; Manufacturing methods related thereto
    • H01L2224/02Bonding areas; Manufacturing methods related thereto
    • H01L2224/04Structure, shape, material or disposition of the bonding areas prior to the connecting process
    • H01L2224/05Structure, shape, material or disposition of the bonding areas prior to the connecting process of an individual bonding area
    • H01L2224/0554External layer
    • H01L2224/05573Single external layer
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2224/00Indexing scheme for arrangements for connecting or disconnecting semiconductor or solid-state bodies and methods related thereto as covered by H01L24/00
    • H01L2224/01Means for bonding being attached to, or being formed on, the surface to be connected, e.g. chip-to-package, die-attach, "first-level" interconnects; Manufacturing methods related thereto
    • H01L2224/10Bump connectors; Manufacturing methods related thereto
    • H01L2224/15Structure, shape, material or disposition of the bump connectors after the connecting process
    • H01L2224/16Structure, shape, material or disposition of the bump connectors after the connecting process of an individual bump connector
    • H01L2224/161Disposition
    • H01L2224/16151Disposition the bump connector connecting between a semiconductor or solid-state body and an item not being a semiconductor or solid-state body, e.g. chip-to-substrate, chip-to-passive
    • H01L2224/16221Disposition the bump connector connecting between a semiconductor or solid-state body and an item not being a semiconductor or solid-state body, e.g. chip-to-substrate, chip-to-passive the body and the item being stacked
    • H01L2224/16225Disposition the bump connector connecting between a semiconductor or solid-state body and an item not being a semiconductor or solid-state body, e.g. chip-to-substrate, chip-to-passive the body and the item being stacked the item being non-metallic, e.g. insulating substrate with or without metallisation
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2224/00Indexing scheme for arrangements for connecting or disconnecting semiconductor or solid-state bodies and methods related thereto as covered by H01L24/00
    • H01L2224/73Means for bonding being of different types provided for in two or more of groups H01L2224/10, H01L2224/18, H01L2224/26, H01L2224/34, H01L2224/42, H01L2224/50, H01L2224/63, H01L2224/71
    • H01L2224/732Location after the connecting process
    • H01L2224/73201Location after the connecting process on the same surface
    • H01L2224/73203Bump and layer connectors
    • H01L2224/73204Bump and layer connectors the bump connector being embedded into the layer connector
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2224/00Indexing scheme for arrangements for connecting or disconnecting semiconductor or solid-state bodies and methods related thereto as covered by H01L24/00
    • H01L2224/91Methods for connecting semiconductor or solid state bodies including different methods provided for in two or more of groups H01L2224/80 - H01L2224/90
    • H01L2224/92Specific sequence of method steps
    • H01L2224/921Connecting a surface with connectors of different types
    • H01L2224/9212Sequential connecting processes
    • H01L2224/92122Sequential connecting processes the first connecting process involving a bump connector
    • H01L2224/92125Sequential connecting processes the first connecting process involving a bump connector the second connecting process involving a layer connector
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2924/00Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
    • H01L2924/01Chemical elements
    • H01L2924/01079Gold [Au]
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01LSEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2924/00Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
    • H01L2924/10Details of semiconductor or other solid state devices to be connected
    • H01L2924/146Mixed devices
    • H01L2924/1461MEMS
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K1/00Printed circuits
    • H05K1/02Details
    • H05K1/03Use of materials for the substrate
    • H05K1/0306Inorganic insulating substrates, e.g. ceramic, glass
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K2201/00Indexing scheme relating to printed circuits covered by H05K1/00
    • H05K2201/09Shape and layout
    • H05K2201/09009Substrate related
    • H05K2201/09127PCB or component having an integral separable or breakable part
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K2201/00Indexing scheme relating to printed circuits covered by H05K1/00
    • H05K2201/10Details of components or other objects attached to or integrated in a printed circuit board
    • H05K2201/10227Other objects, e.g. metallic pieces
    • H05K2201/10287Metal wires as connectors or conductors
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K2201/00Indexing scheme relating to printed circuits covered by H05K1/00
    • H05K2201/10Details of components or other objects attached to or integrated in a printed circuit board
    • H05K2201/10227Other objects, e.g. metallic pieces
    • H05K2201/10295Metallic connector elements partly mounted in a hole of the PCB
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K2201/00Indexing scheme relating to printed circuits covered by H05K1/00
    • H05K2201/10Details of components or other objects attached to or integrated in a printed circuit board
    • H05K2201/10613Details of electrical connections of non-printed components, e.g. special leads
    • H05K2201/10954Other details of electrical connections
    • H05K2201/10977Encapsulated connections
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K2203/00Indexing scheme relating to apparatus or processes for manufacturing printed circuits covered by H05K3/00
    • H05K2203/07Treatments involving liquids, e.g. plating, rinsing
    • H05K2203/0703Plating
    • H05K2203/0733Method for plating stud vias, i.e. massive vias formed by plating the bottom of a hole without plating on the walls
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K2203/00Indexing scheme relating to apparatus or processes for manufacturing printed circuits covered by H05K3/00
    • H05K2203/14Related to the order of processing steps
    • H05K2203/1446Treatment after insertion of lead into hole, e.g. bending, cutting, caulking or curing of adhesive but excluding soldering
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00Apparatus or processes for manufacturing printed circuits
    • H05K3/30Assembling printed circuits with electric components, e.g. with resistor
    • H05K3/32Assembling printed circuits with electric components, e.g. with resistor electrically connecting electric components or wires to printed circuits
    • H05K3/321Assembling printed circuits with electric components, e.g. with resistor electrically connecting electric components or wires to printed circuits by conductive adhesives
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00Apparatus or processes for manufacturing printed circuits
    • H05K3/30Assembling printed circuits with electric components, e.g. with resistor
    • H05K3/32Assembling printed circuits with electric components, e.g. with resistor electrically connecting electric components or wires to printed circuits
    • H05K3/328Assembling printed circuits with electric components, e.g. with resistor electrically connecting electric components or wires to printed circuits by welding
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00Apparatus or processes for manufacturing printed circuits
    • H05K3/40Forming printed elements for providing electric connections to or between printed circuits
    • H05K3/4007Surface contacts, e.g. bumps
    • H05K3/4015Surface contacts, e.g. bumps using auxiliary conductive elements, e.g. pieces of metal foil, metallic spheres
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00Apparatus or processes for manufacturing printed circuits
    • H05K3/40Forming printed elements for providing electric connections to or between printed circuits
    • H05K3/42Plated through-holes or plated via connections
    • H05K3/423Plated through-holes or plated via connections characterised by electroplating method
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05KPRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K3/00Apparatus or processes for manufacturing printed circuits
    • H05K3/46Manufacturing multilayer circuits
    • H05K3/4644Manufacturing multilayer circuits by building the multilayer layer by layer, i.e. build-up multilayer circuits
    • H05K3/4652Adding a circuit layer by laminating a metal foil or a preformed metal foil pattern

Definitions

  • This invention relates to an electrode array or flexible circuit, electronics package and a method of bonding a flexible circuit or electrode array to an integrated circuit or electronics package.
  • Arrays of electrodes for neural stimulation are commonly used for a variety of purposes. Some examples include U.S. Pat. No. 3,699,970 to Brindley, which describes an array of cortical electrodes for visual stimulation. Each electrode is attached to a separate inductive coil for signal and power. U.S. Pat. No. 4,573,481 to Bullara describes a helical electrode to be wrapped around an individual nerve fiber. U.S. Pat. No. 4,837,049 to Byers describes spike electrodes for neural stimulation. Each spike electrode pierces neural tissue for better electrical contact. U.S. Pat. No. 5,215,088 to Norman describes an array of spike electrodes for cortical stimulation. U.S. Pat. No. 5,109,844 to de Juan describes a flat electrode array placed against the retina for visual stimulation. U.S. Pat. No. 5,935,155 to Humayun describes a retinal prosthesis for use with a flat retinal array.
  • the consistency of the retina is comparable to that of wet tissue paper and the biological media inside the eye is a corrosive saline liquid environment.
  • the device to be placed against the retina in addition to being comprised of biocompatible, electrochemically stable materials, must appropriately conform to the curvature of the eye, being sufficiently flexible and gentle in contact with the retina to avoid tissue damage, as discussed by Schneider, et al. It is also desirable that this device, an electrode array, provides a maximum density of stimulation electrodes.
  • a commonly accepted design for an electrode array is a very thin, flexible conductor cable. It is possible to fabricate a suitable electrode array using discrete wires, but with this approach, a high number of stimulation electrodes cannot be achieved without sacrificing cable flexibility (to a maximum of about 16 electrodes).
  • a lithographically fabricated thin film flex circuit electrode array overcomes such limitations.
  • a thin film flex circuit electrode array can be made as thin as 10 um ( ⁇ 0.0005 inches) while accommodating about 60 electrodes in a single circuit routing layer.
  • the flex circuit electrode array is essentially a passive conductor ribbon that is an array of electrode pads, on one end, that contact the retina and on the other end an array of bond pads that must individually mate electrically and mechanically to the electrical contacts of a hermetically sealed electronics package. These contacts may emerge on the outside of the hermetic package as an array of protruding pins or as vias flush to a package surface.
  • a suitable interconnection method must not only serve as the interface between the two components, but must also provide electrical insulation between neighboring pathways and mechanical fastening between the two components.
  • the package contacts are feedthrough pins to which discrete wires are welded and subsequently encapsulated with polymer materials. Such is the case in heart pacemaker and cochlear implant devices. Flexible circuits are not commonly used, if at all, as external components of proven implant designs. The inventor is unaware of prior art describing the welding of contacts to flex circuits.
  • the CSP is aligned to a corresponding metal pad array on the flex circuit and subjected to a solder reflow to create the interconnection.
  • a metallurgical interconnect is achieved by solder wetting.
  • the CSP assembly is then underfilled with an epoxy material to insulate the solder bumps and to provide a pre-load force from the shrinkage of the epoxy.
  • Direct chip attach methods are referred to as chip-on-flex (COF) and chip-on-board (COB).
  • COF chip-on-flex
  • COB chip-on-board
  • C4 Controlled Collapse Chip Connection
  • Flipchip enables minimization of the package footprint, saving valuable space on the circuit, since it does not require a fan out of wirebonds.
  • solder ball attach is the most common method of forming an interconnect.
  • a less developed approach to flipchip bonding is the use of conductive adhesive, such as epoxy or polyimide, bumps to replace solder balls.
  • These bumps are typically silver-filled epoxy or polyimide, although electrically conductive particulate of select biocompatible metal, such as platinum, iridium, titanium, platinum alloys, iridium alloys, or titanium alloys in dust, flake, or powder form, may alternatively be used. This method does not achieve a metallurgical bond, but relies on adhesion.
  • Polymer bump flip chip also requires underfill encapsulation. Conceivably, polymer bump attachment could be used on a chip scale package as well. COB flipchip attach can also be achieved by using gold stud bumps, as an alternative to solder balls. The gold bumps of the chip are bonded to gold contacts on the hard substrate by heat and pressure.
  • BBUL Bumpless Build Up Layer
  • Known deposition techniques for a bond such as an electrically conductive metal bond or “rivet” are limited to thin layers.
  • Plating is one such known method that does not result in an acceptable bond. It is not known how to plate shiny platinum in layers greater than approximately 1 to 5 microns because the dense platinum layer peels off, probably due to internal stresses. Black platinum lacks the strength to be a good mechanical attachment, and also lack good electrical conductivity.
  • An implantable electronic device comprising a hermetic electronics control unit that is typically mounted on a substrate that is bonded to a flexible circuit by an electroplated platinum or gold rivet-shaped connection.
  • the resulting electronics assembly is biocompatible and long-lived when implanted in living tissue, such as in an eye or ear.
  • FIG. 1 illustrates a perspective cutaway view of an eye containing a flexible circuit electrode array.
  • FIG. 2 is a side view of an electronics package.
  • FIG. 3 illustrates a cutaway side view of an electronics package.
  • FIG. 4 is a top view of a flex circuit without the electronics package.
  • FIG. 5 presents a side view of a flex circuit with the electronics package.
  • FIG. 6 is a side view of a flex circuit that is bonded with adhesive to a hybrid substrate.
  • FIG. 7 is a series of illustrations of a flexible circuit being bonded using conductive metal pads to a hybrid substrate.
  • FIG. 8 is a series of illustrations of weld staple bonding of a flexible circuit to a hybrid substrate.
  • FIG. 9 is a sequence of steps illustrating tail-latch interconnect bonding of a flexible circuit to a hybrid substrate.
  • FIG. 10 is a sequence of steps illustrating formation of an integrated interconnect by vapor deposition.
  • FIG. 11 is a side view of a flexible circuit bonded to a rigid array.
  • FIG. 12 is a side view of an electronics control unit bonded to an array.
  • FIG. 13 is a cross-sectional view of a bonded assembly in stepwise fashion.
  • FIG. 14 is an electroplating equipment schema.
  • FIG. 15 is a three-electrode electroplating cell schema.
  • FIG. 16 is a plot of showing the plating current density decrease with hole size.
  • FIG. 17 a is a scanning electron micrograph of a polyimide surface before plating magnified 850 times.
  • FIG. 17 b is a scanning electron micrograph of electrochemically deposited rivets magnified 850 times.
  • FIG. 18 is a side view of a flex circuit that is bonded with adhesive to a hybrid substrate with a higher underfill.
  • the present invention provides a flexible circuit electronics package and a method of bonding a flexible circuit to a hermetic integrated circuit which is useful for a number of applications, including implantation in living tissue as a neural interface, such as a retinal electrode array or an electrical sensor.
  • the tissue paper thin flexible circuit 18 FIG. 1 , transmits electrical signals to the eye 2 by means of electrodes that are located in a stimulating electrode array 10 , that are in contact with the retina 14 . It is obvious that in addition to a stimulating electrode array or sensing electrode, the electrodes may be contacts connecting to remote electrodes.
  • FIG. 1 illustrates the electronics control unit 20 in a perspective cutaway view of an eye 2 containing a flexible circuit electrode array 18 .
  • the electronics control unit 20 is hermetically sealed.
  • the electronics control unit 20 may be a hermetic ceramic case with electronics inside, or it may be a hermetically sealed integrated circuit, or any other environmentally sealed electronics package.
  • the stimulating electrode array 10 is implanted on the retina 14 .
  • Flexible circuit ribbon 24 connects the stimulating electrode array 10 to the electronics control unit 20 .
  • the flexible circuit ribbon 24 preferably passes through the sclera 16 of the eye 2 at incision 12 .
  • Another embodiment of the invention is the flexible circuit ribbon 24 replaced by alternative means of electrical interconnection, such as fine wires or thin cable.
  • the lens 4 of the eye 2 is located opposite the retina 14 .
  • a coil 28 which detects electronic signals such as of images or to charge the electronics control unit 20 power supply, located outside the eye 2 , near the lens 4 , is connected to the electronics control unit 20 by wire 30 .
  • FIG. 2 illustrates a side view of the hermetic electronics control unit 20 and the input/output contacts 22 that are located on the bottom of the unit 20 .
  • the input/output contacts 22 are bonded in the completed assembly to the flexible circuit 18 .
  • Thick film pad 23 is formed by known thick film technology, such as silk screening or plating.
  • FIG. 3 illustrates a cutaway side view of the hermetic electronics control unit 20 .
  • the pad 23 facilitates attachment of wire 30 , and is preferably comprised of a biocompatible material such as platinum, iridium, or alloys thereof, and is preferably comprised of platinum paste.
  • Wire 30 is preferably bonded to pad 23 by welding.
  • the microelectronics assembly 48 is mounted on the hybrid substrate 44 . Vias 46 pass through the substrate 44 to input/output contacts 22 . Electrical signals arrive by wire 30 and exit the electronics control unit 20 by input/output contacts 22 .
  • FIG. 4 A top view of the flexible circuit 18 is illustrated in FIG. 4 .
  • Electrical signals from the electronics control unit 20 pass into bond pads 32 , which are mounted in bond pad end 33 .
  • Flexible electrically insulating substrate 38 is preferably comprised of polyimide.
  • the signals pass from the bond pads 32 along traces 34 , which pass along flexible circuit ribbon 24 to the stimulating electrode array 10 .
  • the array 10 contains the electrodes 36 , which are implanted to make electrical contact with the retina 14 of the eye 2 , illustrated in FIG. 1 .
  • An alternative bed of nails embodiment for the electrodes 36 is disclosed by Byers, et al. in U.S. Pat. No. 4,837,049.
  • FIG. 5 the hermetic electronics control unit 20 is illustrated mounted to flexible circuit 18 .
  • the electrical control unit 20 In order to assure electrical continuity between the electronics control unit 20 and the flexible circuit 18 , the electrical control unit 20 must be intimately bonded to the flexible circuit 18 on the bond pad end 33 .
  • a cutaway of the electronics control unit 20 ( FIG. 5 ) illustrates a bonded connection 42 .
  • the flexible electrically insulating substrate 38 is very thin and flexible and is able to conform to the curvature of the retina 14 ( FIG. 1 ), when implanted thereon.
  • a preferred embodiment of the invention shows the method of bonding the hybrid substrate 244 to the flexible circuit 218 using electrically conductive adhesive 281 , such as a polymer, which may include polystyrene, epoxy, or polyimide, which contains electrically conductive particulate of select biocompatible metal, such as platinum, iridium, titanium, platinum alloys, iridium alloys, or titanium alloys in dust, flake, or powder form.
  • electrically conductive adhesive 281 such as a polymer, which may include polystyrene, epoxy, or polyimide, which contains electrically conductive particulate of select biocompatible metal, such as platinum, iridium, titanium, platinum alloys, iridium alloys, or titanium alloys in dust, flake, or powder form.
  • the hybrid substrate 244 which may alternatively be an integrated circuit or electronic array, and the input/output contacts 222 are prepared for bonding by placing conductive adhesive 281 on the input/output contacts 222 .
  • the rigid integrated circuit 244 is preferably comprised of a ceramic, such as alumina or silicon.
  • the flexible circuit 218 is preferably prepared for bonding to the hybrid substrate 244 by placing conductive adhesive 281 on bond pads 232 .
  • the adhesive 281 may be coated with an electrically conductive biocompatible metal.
  • the flexible circuit 218 contains the flexible electrically insulating substrate 238 , which is preferably comprised of polyimide.
  • the bond pads 232 are preferably comprised of an electrically conductive material that is biocompatible when implanted in living tissue, and are preferably platinum or a platinum alloy, such as platinum-iridium.
  • step c illustrates the cross-sectional view A-A of step b.
  • the conductive adhesive 281 is shown in contact with and resting on the bond pads 232 .
  • Step d shows the hybrid substrate 244 in position to be bonded to the flexible circuit 218 .
  • the conductive adhesive 281 provides an electrical path between the input/output contacts 222 and the bond pads 232 .
  • Step c illustrates the completed bonded assembly wherein the flexible circuit 218 is bonded to the hybrid substrate 144 , thereby providing a path for electrical signals to pass to the living tissue from the electronics control unit (not illustrated).
  • the assembly has been electrically isolated and hermetically sealed with adhesive underfill 280 , which is preferably epoxy.
  • FIG. 7 illustrates the steps of an alternative embodiment to bond the hybrid substrate 244 to flexible circuit 218 by studbumping the hybrid substrate 244 and flexible electrically insulating substrate 238 prior to bonding the two components together by a combination of heat and/or pressure, such as ultrasonic energy.
  • the hybrid substrate 244 is prepared for bonding by forming a studbump 260 on the input/output contacts 222 .
  • the studbump is formed by known methods and is preferably comprised of an electrically conductive material that is biocompatible when implanted in living tissue if exposed to a saline environment. It is preferably comprised of metal, preferably biocompatible metal, or gold or of gold alloys. If gold is selected, then it must be protected with a water resistant adhesive or underfill 280 .
  • the studbump 260 may be comprised of an insulating material, such as an adhesive or a polymer, which is coated with an electrically conductive coating of a material that is biocompatible and stable when implanted in living tissue, while an electric current is passed through the studbump 260 .
  • an insulating material such as an adhesive or a polymer
  • an electrically conductive coating of a material that is biocompatible and stable when implanted in living tissue, while an electric current is passed through the studbump 260 .
  • One such material coating may preferably be platinum or alloys of platinum, such as platinum-iridium, where the coating may be deposited by vapor deposition, such as by ion-beam assisted deposition, or electrochemical means.
  • step b presents the flexible circuit 218 , which comprises the flexible electrically insulating substrate 238 and bond pads 232 .
  • the flexible circuit 218 is prepared for bonding by the plating bond pads 232 with an electrically conductive material that is biocompatible when implanted in living tissue, such as with a coating of platinum or a platinum alloy. Studbumps 260 are then formed on the plated pad 270 by known methods.
  • Step c illustrates cross-section A-A of step b, wherein the flexible circuit 218 is ready to be mated with the hybrid substrate 244 .
  • step d illustrates the assembly of hybrid substrate 244 flipped and ready to be bonded to flexible circuit 218 .
  • the studbumps 260 on either side may be flattened by known techniques such as coining. Pressure is applied to urge the mated studbumps 260 together as heat is applied to cause the studbumps to bond by a diffusion or a melting process.
  • the bond may preferably be achieved by thermosonic or thermocompression bonding, yielding a strong, electrically conductive bonded connection 242 , as illustrated in step e.
  • An example of a thermosonic bonding method is ultrasound.
  • the bonded assembly is completed by placing an adhesive underfill 280 between the flexible circuit 218 and the hybrid substrate 244 , also increasing the strength of the bonded assembly and electrically isolating each bonded connection.
  • the adhesive underfill 280 is preferably epoxy.
  • FIG. 8 illustrates the steps of a further alternative embodiment to bond the hybrid substrate 44 to flexible circuit 18 by weld staple bonding the substrate 244 and flexible electrically insulating substrate 38 together.
  • step a a top view of the flexible circuit 18 is shown.
  • Flexible circuit 18 is comprised of flexible electrically insulating substrate 38 , which is preferably polyimide, and bond pads 32 having a through hole 58 therethrough each bond pad 32 and through the top and bottom surfaces of flexible circuit 18 .
  • the bond pads 32 are comprised of an electrically conductive and biocompatible material which is stable when implanted in living tissue, and which is preferably platinum or a platinum alloy, such as platinum-iridium.
  • step b presents section A-A, which is shown in the illustration of step a.
  • the through holes 58 pass completely through each bond pad 58 , preferably in the center of the bond pad 58 . They are preferably formed by plasma etching.
  • the bond pads 58 are not covered on the top surface of flexible circuit 18 by flexible electrically insulating substrate 38 , thereby creating bond pad voids 56 .
  • step c shows the side view of hybrid substrate 44 with input/output contacts 22 on one surface thereof.
  • the hybrid substrate 44 is positioned, in step d; to be bonded to the flexible circuit 18 by placing the parts together such that the input/output contacts 22 are aligned with the bond pads 32 .
  • wire 52 which is preferably a wire, but may equally well be a ribbon or sheet of weldable material that is also preferably electrically conductive and biocompatible when implanted in living tissue, is attached to input/output contact 22 and bond pad 32 to bond each aligned pair together.
  • the wire 52 is preferably comprised of platinum, or alloys of platinum, such as platinum-iridium.
  • the bond is preferably formed by welding using the parallel gap welder 50 , which moves up and down to force the wire 52 into the through hole 58 and into contact with input/output contact 22 . This process is repeated for each aligned set of input/output contacts 22 and bond pads 32 , as shown in step e.
  • step f The weld staple interconnect bonding process is completed, as shown in step f, by cutting the wire 54 , leaving each aligned set of input/output contacts 22 and bond pads 32 electrically connected and mechanically bonded together by staple 54 .
  • FIG. 9 illustrates yet another embodiment for attaching the hybrid substrate 244 to a flexible circuit 218 by using a tail-ball 282 component, as shown in step a.
  • the hybrid substrate 244 is preferably comprised of a ceramic material, such as alumina or silicon.
  • a wire preferably made of platinum or another electrically conductive, biocompatible material, is fabricated to have a ball on one end, like the preferred tail-ball 282 illustrated in step a.
  • the tail-ball 282 has tail 284 attached thereto, as shown in the side view of step a.
  • the tail-ball 282 is aligned with input/output contact 222 on hybrid substrate 244 , in preparation to being bonded to flexible circuit 218 , illustrated in step b.
  • step b illustrates flexible electrically insulating substrate 238 , which is preferably comprised of polyimide, having the through hole 237 passing completely thorough the thickness and aligned with the tail 284 .
  • the bond pads 232 are exposed on both the top and bottom surfaces of the flexible circuit 218 , by voids 234 , enabling electrical contact to be made with input/output contacts 222 of the hybrid substrate 244 .
  • the voids are preferably formed by plasma etching.
  • step c which illustrates section A-A of step b, shows the hybrid substrate 244 in position to be bonded to and aligned with flexible circuit 218 .
  • the tails 284 are each placed in through hole 237 . Pressure is applied and the tail-balls 282 are placed in intimate contact with bond pads 232 and input/output contacts 222 .
  • Step c illustrates that each of the tails 284 is bent to make contact with the bond pads 232 .
  • the bonding process is completed by bonding, preferably by welding, each of the tails 284 , bond pads 232 , tail-balls 282 , and input/output contacts 222 together, thus forming a mechanical and electrical bond.
  • Locking wire 262 is an optional addition to assure that physical contact is achieved in the bonded component.
  • the process is completed by underfilling the gap with an electrically insulating and biocompatible material (not illustrated), such as epoxy.
  • FIG. 10 illustrates a further alternative embodiment to creating a flexible circuit that is electrically and adhesively bonded to a hermetic rigid electronics package.
  • the flexible circuit is fabricated directly on the rigid substrate.
  • Step a shows the hybrid substrate 44 , which is preferably a ceramic, such as alumina or silicon, having a total thickness of about 0.012 inches, with patterned vias 46 therethrough.
  • the vias 46 are preferably comprised of frit containing platinum.
  • the routing 35 is patterned on one side of the hybrid substrate 44 by known techniques, such as photolithography or masked deposition. It is equally possible to form routing 35 on both sides of the substrate 44 .
  • the hybrid substrate 44 has an inside surface 45 and an outside surface 49 .
  • the routing 35 will carry electrical signals from the integrated circuit, that is to be added, to the vias 46 , and ultimately will stimulate the retina (not illustrated).
  • the routing 35 is patterned by know processes, such as by masking during deposition or by post-deposition photolithography.
  • the routing 35 is comprised of a biocompatible, electrically conductive, patternable material, such at platinum.
  • Step c illustrates formation of the release coat 47 on the outside surface 49 of the hybrid substrate 44 .
  • the release coat 47 is deposited by known techniques, such as physical vapor deposition.
  • the release coat 47 is removable by know processes such as etching. It is preferably comprised of an etchable material, such as aluminum.
  • Step d illustrates the formation of the traces 34 on the outside surface 49 of the hybrid substrate 44 .
  • the traces 34 are deposited by a known process, such as physical vapor deposition or ion-beam assisted deposition. They may be patterned by a known process, such as by masking during deposition or by post-deposition photolithography.
  • the traces 34 are comprised of an electrically conductive, biocompatible material, such as platinum, platinum alloys, such as platinum-iridium, or titanium-platinum.
  • the traces 34 conduct electrical signals along the flexible circuit 18 and to the stimulating electrode array 10 , which were previously discussed and are illustrated in FIG. 4 .
  • Step e illustrates formation of the flexible electrically insulating substrate 38 by known techniques, preferably liquid precursor spinning.
  • the flexible electrically insulating substrate 38 is preferably comprised of polyimide.
  • the flexible electrically insulating substrate electrically insulates the traces 34 . It is also biocompatible when implanted in living tissue.
  • the coating is about 5 um thick.
  • the liquid precursor is spun coated over the traces 34 and the entire outside surface 49 of the hybrid substrate 44 , thereby forming the flexible electrically insulating substrate 38 .
  • the spun coating is cured by known techniques.
  • Step f illustrates the formation of voids in the flexible electrically insulating substrate 38 thereby revealing the traces 34 .
  • the flexible electrically insulating substrate is preferably patterned by known techniques, such as photolithography with etching.
  • Step g illustrates the rivets 51 having been formed over and in intimate contact with traces 34 .
  • the rivets 51 are formed by known processes, and are preferably formed by electrochemical deposition of a biocompatible, electrically conductive material, such as platinum or platinum alloys, such as platinum-iridium.
  • Step h illustrates formation of the metal layer 53 over the rivets 51 in a controlled pattern, preferably by photolithographic methods, on the outside surface 49 .
  • the rivets 51 and the metal layer 53 are in intimate electrical contact.
  • the metal layer 53 may be deposited by known techniques, such as physical vapor deposition, over the entire surface followed by photolithographic patterning, or it may be deposited by masked deposition.
  • the metal layer 53 is formed of an electrically conductive, biocompatible material, which in a preferred embodiment is platinum.
  • the patterned metal layer 53 forms traces 34 and electrodes 36 , which conduct electrical signals from the electronics control unit 20 and the electrodes 36 (see FIGS. 4 and 5 ).
  • Step i illustrates the flexible electrically insulating substrate 38 applied over the outside surface 49 of the rigid substrate 44 , as in step e.
  • the flexible electrically insulating substrate 38 covers the rivets 51 and the metal layer 53 .
  • Step j illustrates the hybrid substrate 44 having been cut by known means, preferably by a laser or, in an alternative embodiment, by a diamond wheel, thereby creating cut 55 .
  • the portion of hybrid substrate 44 that will be removed is called the carrier 60 .
  • the flexible electrically insulating substrate 38 is patterned by known methods, such as photolithographic patterning, or it may be deposited by masked deposition, to yield voids that define the electrodes 36 .
  • the electrodes 36 transmit electrical signals directly to the retina of the implanted eye (see FIG. 4 )
  • Step k illustrates flexible circuit 18 attached to the hybrid substrate 44 .
  • the carrier 60 is removed by utilizing release coat 47 .
  • release coat 47 is etched by known means to release carrier 60 , leaving behind flexible circuit 18 .
  • Step l illustrates the implantable electronic device of a flexible circuit 18 and an intimately bonded hermetic electronics control unit 20 .
  • the electronics control unit 20 which contains the microelectronics assembly 48 , is hermetically sealed with header 62 bonded to rigid circuit substrate 44 .
  • the header 62 is comprised of a material that is biocompatible when implanted in living tissue and that is capable of being hermetically sealed to protect the integrated circuit electronics from the environment.
  • FIG. 11 illustrates an electronics control unit 320 attached to flexible electrically insulating substrate 338 , which is preferably comprised of polyimide, by bonded connections 342 .
  • the electronics control unit 320 is preferably a hermetically sealed integrated circuit, although in an alternative embodiment it may be a hermetically sealed hybrid assembly.
  • Bonded connections 342 are preferably conductive adhesive, although they may alternatively be solder bumps. The bond area is underfilled with an adhesive 380 .
  • Rigid stimulating electrode array 310 is attached to the flexible electrically insulating substrate 338 by bonded connections 342 .
  • FIG. 12 illustrates an electronics control unit 320 attached to rigid stimulating electrode array 310 by bonded connections 342 .
  • the bond area is then underfilled with an adhesive 380 , preferably epoxy.
  • Bonded connections 342 are preferably conductive adhesive, although they may alternatively be solder bumps.
  • the bonding steps are illustrated in FIG. 13 for a flex circuit assembly that is bonded with rivets 61 that are created in situ by a deposition process, preferably by electroplating.
  • the rivets 61 are rivet-shaped electrical connections.
  • the substrate 68 is shown generally in FIG. 13 . It is comprised of the hybrid substrate 44 , which is preferably a ceramic, such as alumina or silicon.
  • the silicon would preferably be coated with a biocompatible material to achieve biocompatibility of the silicon, which is well known to slowly dissolve when implanted in living tissue.
  • the hybrid substrate 44 preferably contains vias 46 that pass through the thickness of the hybrid substrate 44 , see FIG. 13 , step (a). Vias 46 are not required to enable this invention, and are not present in alternative embodiments. It is preferred that the hybrid substrate 44 be rigid, although alternative embodiments utilize a non-rigid substrate.
  • the vias 46 are integral with electrically conductive routing 35 that has been placed on the surface of the hybrid substrate 44 by known techniques. The routing is preferably comprised of a stable biocompatible material, such as platinum, a platinum alloy, or gold, most preferably platinum.
  • a flexible electrically insulating substrate 38 is preferably comprised of two layers of an electrically insulating material, such as a polymer.
  • a polymer such as a polymer.
  • Known preferred polymer materials are polyimide or Parylene.
  • Parylene refers to polyparaxylylene, a known polymer that has excellent implant characteristics.
  • Parylene manufactured by Specialty Coating Systems (SCS), a division of Cookson Electronic Equipment Group, located in Indianapolis, Ind., is a preferred material. Parylene is available in various forms, such as Parylene C, Parylene D, and Parylene N, each having different properties. The preferred form is Parylene C.
  • the flexible electrically insulating substrate layers 38 are preferably of approximately equal thicknesses, as illustrated in FIG. 13 , step (a).
  • a trace 65 is also illustrated in FIG. 13 , step (a), where trace 65 may be at least one, but preferably more than one, trace 65 that is electrically conductive.
  • the traces 65 are integrally bonded to bond pads 63 .
  • the bond pads 63 each have a bond pad hole 64 therethrough, which is in approximate alignment with first hole 57 in first electrically insulating substrate 37 and second hole 59 in the second flexible electrically insulating substrates 38 , such that there is a hole, with centers approximately aligned, through the thickness of the flexible assembly 66 .
  • the flexible assembly 66 is placed next to the hybrid substrate in preparation for bonding, FIG. 13 , step (b).
  • the flexible assembly aligned holes that are formed by first substrate holes 57 , bond pad holes 64 , and second substrate holes 59 are aligned with the routing 35 .
  • there is at least one via 46 although no via 46 is required.
  • an adhesive layer 39 is applied to adhesively bond the assembly together.
  • the adhesive is preferably epoxy, silicone, or polyimide. In alternative embodiments, the assembly is not adhesively bonded.
  • a rivet 61 is formed in each flexible substrate hole to bond the assembly together.
  • the rivets 61 are preferably formed by a deposition process, most preferably electroplating.
  • the rivets 61 are comprised of a biocompatible, electrically conductive material, preferably platinum, although alternative embodiments may utilize platinum alloys (e.g. platinum-iridium or platinum-rhodium), iridium, gold, palladium, or palladium alloys. It is most preferred that rivet 61 be comprised of electroplated platinum, called “plated platinum” herein.
  • a method to produce plated platinum according to the present invention comprising connecting a common electrode 402 , the anode, and a bonded assembly 70 , the cathode, to a voltage to current converter 406 with a wave form generator 430 and monitor 428 , preferably an oscilloscope.
  • the common electrode 402 , bonded assembly 70 , a reference electrode 410 , for use as a reference in controlling the power source, which is comprised of a voltage to current converter 406 and a waveform generator 430 , and an electroplating solution are placed in a electroplating cell 400 having a means for mixing 414 the electroplating solution.
  • Power may be supplied to the electrodes with constant voltage, constant current, pulsed voltage, scanned voltage or pulsed current to drive the electroplating process.
  • the waveform generator 430 and voltage to current converter 406 is set such that the rate of deposition will cause the platinum to deposit as plated platinum, the rate being greater than the deposition rate necessary to form shiny platinum and less than the deposition rate necessary to form platinum black.
  • the plated material can be pure platinum.
  • other materials can be introduced during the plating process, if so desired, but these materials are not necessary to the formation of plated platinum.
  • the electroplating cell 400 is preferably a 50 ml to 150 ml four neck glass flask or beaker
  • the common electrode 402 , or anode is preferably a large surface area platinum wire or platinum sheet
  • the reference electrode 410 is preferably a Ag/AgCl electrode (silver, silver chloride electrode)
  • the bonded assembly 70 , or cathode can be any suitable material depending on the application and can be readily chosen by one skilled in the art.
  • Preferable examples of the bonded assembly 70 include, but are not limited to, platinum, iridium, rhodium, gold, tantalum, titanium or niobium, preferably platinum.
  • the means for mixing 414 is preferably a magnetic stirrer ( FIG. 15 ).
  • the plating solution is preferably 3 to 30 millimoles ammonium hexachloroplatinate in 0.4 moles of disodium hydrogen phosphate, but may be derived from any chloroplatinic acid or bromoplatinic acid or other electroplating solution.
  • the preferable plating temperature is approximately 24′-26° C.
  • the electroplating system for pulsed current control is shown in FIGS. 14 and 15 . While constant voltage, constant current, pulsed voltage or pulsed current can be used to control the electroplating process, pulsed current control of the plating process is preferable for plating rivets 61 , which have a height that approximates their diameter.
  • the preferable current range to produce plated platinum which varies from about 50 to 2000 mA/cm 2 , is dependent on the whole dimensions, FIG. 16 , where the response voltage ranges from about ⁇ 0.45 volts to ⁇ 0.85 volts. Applying power in this range with the above solution yields a plating rate in the range of about 0.05 um per minute to 1.0 um per minute, the preferred range for the plating rate of plated platinum.
  • plating conditions including but not limited to the plating solution, surface area of the electrodes, pH, platinum concentration and the presence of additives, are changed the optimal control parameters will change according to basic electroplating principles. Plated platinum will be formed so long as the rate of deposition of the platinum particles is slower than that for the formation of platinum gray and faster than that for the formation of shiny platinum.
  • a thin-layer routing 35 preferably platinum is sputtered and then covered with about 6 um thick flexible assembly 66 , preferably polyimide, with holes in the range from 5 um to 50 um. On each sample, preferably about 100 to 700 or more such holes are exposed for plating of rivets 61 , see FIG. 17 a.
  • SEM micrographs record the rivet surface appearance before plating.
  • the surface is chemically and electrochemically cleaned before plating.
  • the electrodes in the test cell are arranged, so that the bonded assembly 70 (cathode) is physically parallel with the common electrode 402 (anode).
  • the reference electrode 410 is positioned beside the bonded assembly 70 .
  • the plating solution is added to electroplating solution level 411 .
  • the solution is comprised of about 18 millimoles ammonium hexachloroplatinate in about 0.4 moles phosphate buffer solution. The amount of solution used depends on the number of rivets 61 to be plated.
  • the means for mixing 414 preferably a magnetic stirrer, is activated.
  • a voltage waveform is generated, preferably with a 1 msec pulse width as a 500 Hz square wave, which is converted to a current signal through a voltage to current converter 406 .
  • the pulse current is applied to the plating electrode versus anode.
  • the electrode voltage versus Ag/AgCl reference electrode is monitored using an oscilloscope (Tektronix TDS220 Oscilloscope).
  • the current amplitude is adjusted so that the cathodic peak voltage reaches about ⁇ 0.6 v versus the Ag/AgCl reference electrode 410 .
  • the current amplitude is frequently adjusted so that the electrode voltage is kept within ⁇ 0.5 to ⁇ 0.7 v range versus Ag/AgCl reference electrode 410 .
  • Typical plating time is in the range of about 5 to 60 minutes, preferably 15 to 25 minutes.
  • the plated surface is examined under an optical microscope. Optical photomicrographs are taken at both low and high magnifications to record the image of the surface.
  • the plated samples are profiled with a surface profilometer to measure the dimensions of the plated rivet.
  • the total plated rivet has a total height of about 8 to 16 um.
  • the pulsing current amplitudes are averaged for the total plating time and recorded. It is has been demonstrated that the current density increases exponentially with sample hole decrease. The smaller the sample holes, the higher the current density required (see FIG. 16 ).
  • FIGS. 17 a and 17 b An illustrative example of a plated platinum rivet according to the present invention are micrographs produced on a Scanning Electron Microscope (SEM) at 850 ⁇ taken by a JEOL JSM5910 microscope, FIGS. 17 a and 17 b.
  • SEM Scanning Electron Microscope
  • a further preferred embodiment of the invention shows the method of bonding the hybrid substrate 244 to the flexible circuit 218 using electrically conductive adhesive 281 , such as a polymer, which may include polystyrene, epoxy, or polyimide, which contains electrically conductive particulate of select biocompatible metal, such as platinum, iridium, titanium, platinum alloys, iridium alloys, or titanium alloys in dust, flake, or powder form.
  • electrically conductive adhesive 281 such as a polymer, which may include polystyrene, epoxy, or polyimide, which contains electrically conductive particulate of select biocompatible metal, such as platinum, iridium, titanium, platinum alloys, iridium alloys, or titanium alloys in dust, flake, or powder form.
  • step a the hybrid substrate 244 , which may alternatively be an integrated circuit or electronic array, and the input/output contacts 222 are prepared for bonding by placing conductive adhesive 281 on the input/output contacts 222 .
  • the conductive adhesive 281 which includes at least one bump, is cured to become hard.
  • a second conductive adhesive 281 a is applied on top of the first cured conductive adhesive 281 .
  • the rigid integrated circuit 244 is preferably comprised of a ceramic, such as alumina or silicon.
  • the flexible circuit 218 is preferably prepared for bonding to the hybrid substrate 244 by placing conductive adhesive 281 on bond pads 232 .
  • the adhesive 281 may be coated with an electrically conductive biocompatible metal.
  • the flexible circuit 218 contains the flexible electrically insulating substrate 238 , which is preferably comprised of polyimide.
  • the bond pads 232 are preferably comprised of an electrically conductive material that is biocompatible when implanted in living tissue, and are preferably platinum or a platinum alloy, such as platinum-iridium.
  • step c illustrates the cross-sectional view A-A of step b.
  • the conductive adhesive 281 is shown in contact with and resting on the bond pads 232 .
  • Step d shows the hybrid substrate 244 in position being bonded to the flexible circuit 218 .
  • the conductive adhesive 281 resting on the bond pads 232 and the conductive adhesive 281 a resting on the cured conductive adhesive 281 resting on the contacts 222 are cured to yield one conductive adhesive 281 / 281 a / 281 .
  • the conductive adhesive 281 / 281 a / 281 provides an electrical path between the input/output contacts 222 and the bond pads 232 .
  • Step c illustrates the completed bonded assembly wherein the flexible circuit 218 is bonded to the hybrid substrate 244 , thereby providing a path for electrical signals to pass to the living tissue from the electronics control unit (not illustrated).
  • the conductive adhesive 281 / 281 a / 281 is higher than in the embodiment shown in FIG. 6 and the distance between the hybrid substrate 244 and flexible circuit 218 is larger.
  • the assembly has been electrically isolated and hermetically sealed with adhesive underfill 280 , which is preferably epoxy. Since the distance between the hybrid substrate 244 and flexible circuit 218 is larger the underfill 280 is higher in this embodiment.
  • the method of manufacturing an implantable electronic device comprises the following steps:
  • Each layer of conductive adhesive applied on the substrate is preferably cured prior to aligning with the conductive adhesive applied on the flexible assembly.
  • a biocompatible non-conductive adhesive underfill is preferably applied between the substrate and the flexible assembly.
  • the adhesive connecting the contacts on the substrate with the bond pads on the flexible assembly contains epoxy or polyimide filled with electrically conductive biocompatible metal in dust, flake, or powder form.
  • the electrically conductive biocompatible metal preferably comprises silver, gold, platinum, iridium, titanium, platinum alloys, iridium alloys, titanium alloys in, or mixtures thereof.
  • the adhesive connecting the contacts on the substrate with the bond pads on the flexible assembly can alternatively be coated with an electrically conductive biocompatible metal.
  • the adhesive underfill is cured at a pressure of 50 PSI to 100 PSI.
  • the adhesive underfill is preferably cured at a pressure of 60 PSI to 90 PSI.
  • the adhesive underfill is more preferably cured at a pressure of 70 PSI to 85 PSI.
  • the curing process carried out under pressure yields an adhesive with very limited amount of gas bubbles and improved adhesion.
  • the adhesive underfill is cured under pressure at a temperature of 20° C. to 30° C. for 3 h to 50 h.
  • the adhesive underfill is alternatively cured at a temperature of 70° C. to 100° C. for a time of 10 min to 2 h.
  • the height of one or more conductive adhesives on the substrate determines the distance between the substrate and the flexible assembly.
  • the conductive adhesive on the substrate which comprises one or more layer and is preferably in the form of bumps is preferably cured before being aligned with the uncured bumps on the flexible assembly.
  • the hard bumps of conductive adhesives on the substrate push into the soft bumps of the flexible assembly as deep as possible prior to the final curing process. Therefore, the higher the hard bumps on the substrate are the larger is the distance between the substrate and the flexible assembly.
  • the implantable electronic device comprises:
  • a substrate 244 having one or more contacts 222 and two or more layers of conductive adhesive 281 / 281 a on the contacts 222 ;
  • a flexible assembly 218 having one or more bond pads 232 and one or more layers of conductive adhesive 281 on the bond pads 232 ;
  • the substrate comprises a biocompatible ceramic.
  • the biocompatible ceramic comprises alumina.
  • the substrate is rigid and is an electrically insulated substrate circuit.
  • the flexible assembly is a thin substrate circuit.
  • the conductive adhesive provides an electrical path between the input/output contacts and the bond pads.
  • the adhesive underfill is nonconductive and contains epoxy.
  • the following example is illustrative of electroplating platinum as a rivet 61 , according to the present invention.
  • a flexible electrically insulating substrate comprised of a first substrate 37 and a second substrate 38 of polyimide having a total thickness of 6 um. It had 700 first substrate holes 57 , an equal number of matching bond pad holes 64 , and an equal number of matching second substrate holes 59 , all in alignment so as to create a continuous hole through flexible assembly 66 that terminates on routing 35 , arranged in 100 groups of seven on about 40 um centers, FIG. 4 a .
  • the hybrid substrate 44 was alumina and the routing 35 was platinum.
  • the bond pad 63 was platinum.
  • the assembly was cleaned by rinsing three times in 10% HCl. It was further prepared by bubbling for 10 seconds at +/ ⁇ 5V at 1 Hz in phosphate buffered saline. Finally, it was rinsed in deionized water.
  • the electroplating set up according to FIGS. 14 and 15 was comprised of an electroplating cell 400 that was a 100 ml beaker with an electroplating solution level 411 at about the 75 ml level.
  • the solution was 18 millimoles of ammonium hexachloroplatinate in 0.4 moles phosphate buffer solution.
  • the means for mixing 414 was a magnetic stirrer, which was activated.
  • the voltage waveform of 1 msec pulse width as a square wave was generated by an HP 33120A waveform generator, which is converted to current signal through a voltage to current converter 406 .
  • the pulse current was 1 msec in pulse width at 500 Hz square wave.
  • the pulse current was applied on the plating electrode bonded assembly 70 versus common electrode 402 .
  • the electrode voltage versus Ag/AgCl reference electrode 410 was monitored using as a monitor 428 a Tektronix model TDS220 oscilloscope.
  • the current amplitude was increased so that the bonded assembly 70 (cathode) peak voltage reached ⁇ 0.6 v versus the Ag/AgCl reference electrode 410 .
  • the electrode voltage decreased with plating time.
  • the average current density was 660 mA/cm 2 , which generated response voltages of ⁇ 0.5 to ⁇ 0.7 volts, where the voltage was controlled by the current.
  • a 1 msec pulse width square wave was generated by an HP 33120A Arbitrary Waveform Generator. The pulse was converted to a current signal through a voltage to current converter 406 . The pulse current was typically about 1 msec in pulse width as a 500 Hz square wave.
  • the resulting plated platinum rivet 61 was about 32 um diameter on the button end and about 15 um tall, with about 9 um of the height extending above the polyimide substrate. The plated platinum rivet was dense, strong, and electrically conductive.
  • the rivet 61 ( FIG. 13 ) forms an electrically conductive bond with the routing 35 and with the bond pad 63 . It is obvious that the bonded assembly may be stacked with other bonded assemblies forming multiple stacked assemblies with increased stacking density.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Physics & Mathematics (AREA)
  • Power Engineering (AREA)
  • Computer Hardware Design (AREA)
  • General Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Manufacturing & Machinery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Prostheses (AREA)
  • Electrotherapy Devices (AREA)

Abstract

The invention is directed to a method of bonding a hermetically sealed electronics package to an electrode or a flexible circuit and the resulting electronics package that is suitable for implantation in living tissue, such as for a retinal or cortical electrode array to enable restoration of sight to certain non-sighted individuals. The hermetically sealed electronics package is directly bonded to the flex circuit or electrode by electroplating a biocompatible material, such as platinum or gold, effectively forming a plated rivet-shaped connection, which bonds the flex circuit to the electronics package. The resulting electronic device is biocompatible and is suitable for long-term implantation in living tissue.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This patent application claims benefit of U.S. Provisional Application No. 60/778,833, filed Mar. 3, 2006, entitled “Biocompatible Bonding Method and Electronics Package Suitable for Implantation,” the disclosure of which is incorporated herein by reference.
  • This Patent application is a continuation in part of U.S. patent application Ser. No. 10/236,396, filed Sep. 6, 2002, entitled “Biocompatible Bonding Method and Electronics Package Suitable for Implantation” the disclosure of which is incorporated herein by reference and which is a continuation-in-part of U.S. patent application Ser. No. 10/174,349, filed on Jun. 17, 2002, entitled “Biocompatible Bonding Method and Electronics Package Suitable for Implantation,” the disclosure of which is incorporated herein by reference, and which claims benefit of U.S. Provisional Application No. 60/372,062, filed on Apr. 11, 2002, entitled “Platinum Deposition for Electrodes,” the disclosure of which is incorporated herein by reference.
  • The application claims benefit of U.S. patent application Ser. No. 10/226,976, filed on Aug. 23, 2002, now U.S. Pat. No. 6,794,533, entitled “Platinum Electrode and Method for Manufacturing the Same,” the disclosure of which is incorporated herein by reference, and which claims benefit of U.S. Provisional Application No. 60/372,062, filed on Apr. 11, 2002, entitled “Platinum Deposition for Electrodes,” the disclosure of which is incorporated herein by reference.
  • FEDERALLY SPONSORED RESEARCH
  • This invention was made with government support under grant No. R24EY12893-01, awarded by the National Institutes of Health. The government has certain rights in the invention.
  • FIELD OF THE INVENTION
  • This invention relates to an electrode array or flexible circuit, electronics package and a method of bonding a flexible circuit or electrode array to an integrated circuit or electronics package.
  • BACKGROUND OF THE INVENTION
  • Arrays of electrodes for neural stimulation are commonly used for a variety of purposes. Some examples include U.S. Pat. No. 3,699,970 to Brindley, which describes an array of cortical electrodes for visual stimulation. Each electrode is attached to a separate inductive coil for signal and power. U.S. Pat. No. 4,573,481 to Bullara describes a helical electrode to be wrapped around an individual nerve fiber. U.S. Pat. No. 4,837,049 to Byers describes spike electrodes for neural stimulation. Each spike electrode pierces neural tissue for better electrical contact. U.S. Pat. No. 5,215,088 to Norman describes an array of spike electrodes for cortical stimulation. U.S. Pat. No. 5,109,844 to de Juan describes a flat electrode array placed against the retina for visual stimulation. U.S. Pat. No. 5,935,155 to Humayun describes a retinal prosthesis for use with a flat retinal array.
  • Packaging of a biomedical device intended for implantation in the eye, and more specifically for physical contact with the retina, presents a unique interconnection challenge. The consistency of the retina is comparable to that of wet tissue paper and the biological media inside the eye is a corrosive saline liquid environment.
  • Thus, the device to be placed against the retina, in addition to being comprised of biocompatible, electrochemically stable materials, must appropriately conform to the curvature of the eye, being sufficiently flexible and gentle in contact with the retina to avoid tissue damage, as discussed by Schneider, et al. It is also desirable that this device, an electrode array, provides a maximum density of stimulation electrodes. A commonly accepted design for an electrode array is a very thin, flexible conductor cable. It is possible to fabricate a suitable electrode array using discrete wires, but with this approach, a high number of stimulation electrodes cannot be achieved without sacrificing cable flexibility (to a maximum of about 16 electrodes).
  • A lithographically fabricated thin film flex circuit electrode array overcomes such limitations. A thin film flex circuit electrode array can be made as thin as 10 um (<0.0005 inches) while accommodating about 60 electrodes in a single circuit routing layer. The flex circuit electrode array is essentially a passive conductor ribbon that is an array of electrode pads, on one end, that contact the retina and on the other end an array of bond pads that must individually mate electrically and mechanically to the electrical contacts of a hermetically sealed electronics package. These contacts may emerge on the outside of the hermetic package as an array of protruding pins or as vias flush to a package surface. A suitable interconnection method must not only serve as the interface between the two components, but must also provide electrical insulation between neighboring pathways and mechanical fastening between the two components.
  • Many methods exist in the electronics industry for attaching an integrated circuit to a flexible circuit. Commonly used methods include wire-bonding, anisotropic-conductive films, and “flip-chip” bumping. However, none of these methods results in a biocompatible connection. Common materials used in these connections are tin-lead solder, indium and gold. Each of these materials has limitations on its use as an implant. Lead is a known neurotoxin. Indium corrodes when placed in a saline environment. Gold, although relatively inert and biocompatible, migrates in a saline solution, when electric current is passed through it, resulting in unreliable connections.
  • In many implantable devices, the package contacts are feedthrough pins to which discrete wires are welded and subsequently encapsulated with polymer materials. Such is the case in heart pacemaker and cochlear implant devices. Flexible circuits are not commonly used, if at all, as external components of proven implant designs. The inventor is unaware of prior art describing the welding of contacts to flex circuits.
  • Attachment by gold ball bumping has been demonstrated by the Fraunhofer group (Hansjoerg Beutel, Thomas Stieglitz, Joerg Uwe Meyer, “Versatile ‘Microflex’-Based Interconnection Technique,” Proc. SPIE Conf on Smart Electronics and MEMS, San Diego, Cal., March 1998, vol. 3328, pp 174-82.) to rivet a flex circuit onto an integrated circuit. A robust bond can be achieved in this way. However, encapsulation proves difficult to effectively implement with this method. Because the gap between the chip and the flex circuit is not uniform, underfill with epoxy is not practical. Thus, electrical insulation cannot be achieved with conventional underfill technology. Further, as briefly discussed earlier, gold, while biocompatible, is not completely stable under the conditions present in an implant device since it “dissolves” by electromigration when implanted in living tissue and subject to an electric current (see M. Pourbaix, Atlas of Electrochemical Equilibria in Aqueous Solutions, National Association of Corrosion Engineers, Houston, 1974, pp 399-405.).
  • Widespread use of flexible circuits can be found in high volume consumer electronics and automotive applications, such as stereos. These applications are not constrained by a biological environment. Component assembly onto flex circuits is commonly achieved by solder attachment. These flex circuits are also much more robust and bulkier than a typical implantable device. The standard flex circuit on the market is no less than 0.002 inches in total thickness. The trace metallization is etched copper foil, rather than thin film metal. Chip-scale package (CSP) assembly onto these flex circuits is done in ball-grid array (BGA) format, which uses solder balls attached to input-output contacts on the package base as the interconnect structures. The CSP is aligned to a corresponding metal pad array on the flex circuit and subjected to a solder reflow to create the interconnection. A metallurgical interconnect is achieved by solder wetting. The CSP assembly is then underfilled with an epoxy material to insulate the solder bumps and to provide a pre-load force from the shrinkage of the epoxy.
  • Direct chip attach methods are referred to as chip-on-flex (COF) and chip-on-board (COB). There have been some assemblies that utilize gold wirebonding to interconnect bare, integrated circuits to flexible circuits. The flipchip process is becoming a reliable interconnect method. Flipchip technology originates from IBM's Controlled Collapse Chip Connection (C4) process, which evolved to solder reflow technique. Flipchip enables minimization of the package footprint, saving valuable space on the circuit, since it does not require a fan out of wirebonds. While there are a variety of flipchip configurations available, solder ball attach is the most common method of forming an interconnect. A less developed approach to flipchip bonding is the use of conductive adhesive, such as epoxy or polyimide, bumps to replace solder balls. These bumps are typically silver-filled epoxy or polyimide, although electrically conductive particulate of select biocompatible metal, such as platinum, iridium, titanium, platinum alloys, iridium alloys, or titanium alloys in dust, flake, or powder form, may alternatively be used. This method does not achieve a metallurgical bond, but relies on adhesion. Polymer bump flip chip also requires underfill encapsulation. Conceivably, polymer bump attachment could be used on a chip scale package as well. COB flipchip attach can also be achieved by using gold stud bumps, as an alternative to solder balls. The gold bumps of the chip are bonded to gold contacts on the hard substrate by heat and pressure. A recent development in chip-to-package attachment was introduced by Intel Corporation as Bumpless Build Up Layer (BBUL) technology. In this approach, the package is grown (built up) around the die rather than assembling the die into a pre-made package. BBUL presents numerous advantages in reliability and performance over flipchip.
  • Known technologies for achieving a bond between a flexible circuit and an electronics package suffer from biocompatibility issues. Novel applications of a biomedical implant that utilize a flexible circuit attached to a rigid electronics package require excellent biocompatibility coupled with long term mechanical attachment stability, to assure long lived reliable electrical interconnection.
  • Known deposition techniques for a bond, such as an electrically conductive metal bond or “rivet” are limited to thin layers. Plating is one such known method that does not result in an acceptable bond. It is not known how to plate shiny platinum in layers greater than approximately 1 to 5 microns because the dense platinum layer peels off, probably due to internal stresses. Black platinum lacks the strength to be a good mechanical attachment, and also lack good electrical conductivity.
  • Known techniques for bonding an electronic package to a flex circuit do not result in a hermetic package that is suitable for implantation in living tissue. Therefore, it is desired to have a method of attaching a substrate to a flexible circuit that ensures that the bonded electronic package and flex circuit will function for long-term implant applications in living tissue.
  • SUMMARY OF THE INVENTION
  • An implantable electronic device comprising a hermetic electronics control unit that is typically mounted on a substrate that is bonded to a flexible circuit by an electroplated platinum or gold rivet-shaped connection. The resulting electronics assembly is biocompatible and long-lived when implanted in living tissue, such as in an eye or ear.
  • The novel features of the invention are set forth with particularity in the appended claims. The invention will be best understood from the following description when read in conjunction with the accompanying drawings.
  • OBJECTS OF THE INVENTION
  • It is an object of the invention to provide a hermetic, biocompatible electronics package that is attached to a flexible circuit.
  • It is an object of the invention to attach a hermetically sealed electronics package to a flexible circuit for implantation in living tissue.
  • It is an object of the invention to attach a hermetically sealed electronics package to a flexible circuit for implantation in living tissue to transmit electrical signals to living tissue, such as the retina.
  • It is an object of the invention to provide a hermetic, biocompatible electronics package that is attached directly to a substrate.
  • It is an object of the invention to provide a method of bonding a flexible circuit to a substrate with an electroplated rivet-shaped connection.
  • It is an object of the invention to provide a method of plating platinum as a rivet-shaped connection.
  • Other objects, advantages and novel features of the present invention will become apparent from the following detailed description of the invention when considered in conjunction with the accompanying drawing.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates a perspective cutaway view of an eye containing a flexible circuit electrode array.
  • FIG. 2 is a side view of an electronics package.
  • FIG. 3 illustrates a cutaway side view of an electronics package.
  • FIG. 4 is a top view of a flex circuit without the electronics package.
  • FIG. 5 presents a side view of a flex circuit with the electronics package.
  • FIG. 6 is a side view of a flex circuit that is bonded with adhesive to a hybrid substrate.
  • FIG. 7 is a series of illustrations of a flexible circuit being bonded using conductive metal pads to a hybrid substrate.
  • FIG. 8 is a series of illustrations of weld staple bonding of a flexible circuit to a hybrid substrate.
  • FIG. 9 is a sequence of steps illustrating tail-latch interconnect bonding of a flexible circuit to a hybrid substrate.
  • FIG. 10 is a sequence of steps illustrating formation of an integrated interconnect by vapor deposition.
  • FIG. 11 is a side view of a flexible circuit bonded to a rigid array.
  • FIG. 12 is a side view of an electronics control unit bonded to an array.
  • FIG. 13 is a cross-sectional view of a bonded assembly in stepwise fashion.
  • FIG. 14 is an electroplating equipment schema.
  • FIG. 15 is a three-electrode electroplating cell schema.
  • FIG. 16 is a plot of showing the plating current density decrease with hole size.
  • FIG. 17 a is a scanning electron micrograph of a polyimide surface before plating magnified 850 times.
  • FIG. 17 b is a scanning electron micrograph of electrochemically deposited rivets magnified 850 times.
  • FIG. 18 is a side view of a flex circuit that is bonded with adhesive to a hybrid substrate with a higher underfill.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The following description is the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for describing the general principles of the invention. The scope of the invention should be determined with reference to the claims.
  • The present invention provides a flexible circuit electronics package and a method of bonding a flexible circuit to a hermetic integrated circuit which is useful for a number of applications, including implantation in living tissue as a neural interface, such as a retinal electrode array or an electrical sensor. The tissue paper thin flexible circuit 18, FIG. 1, transmits electrical signals to the eye 2 by means of electrodes that are located in a stimulating electrode array 10, that are in contact with the retina 14. It is obvious that in addition to a stimulating electrode array or sensing electrode, the electrodes may be contacts connecting to remote electrodes. FIG. 1 illustrates the electronics control unit 20 in a perspective cutaway view of an eye 2 containing a flexible circuit electrode array 18. The electronics control unit 20 is hermetically sealed. The electronics control unit 20 may be a hermetic ceramic case with electronics inside, or it may be a hermetically sealed integrated circuit, or any other environmentally sealed electronics package. The stimulating electrode array 10 is implanted on the retina 14. Flexible circuit ribbon 24 connects the stimulating electrode array 10 to the electronics control unit 20.
  • The flexible circuit ribbon 24 preferably passes through the sclera 16 of the eye 2 at incision 12. Another embodiment of the invention is the flexible circuit ribbon 24 replaced by alternative means of electrical interconnection, such as fine wires or thin cable. The lens 4 of the eye 2 is located opposite the retina 14. A coil 28, which detects electronic signals such as of images or to charge the electronics control unit 20 power supply, located outside the eye 2, near the lens 4, is connected to the electronics control unit 20 by wire 30.
  • FIG. 2 illustrates a side view of the hermetic electronics control unit 20 and the input/output contacts 22 that are located on the bottom of the unit 20. The input/output contacts 22 are bonded in the completed assembly to the flexible circuit 18. Thick film pad 23 is formed by known thick film technology, such as silk screening or plating.
  • FIG. 3 illustrates a cutaway side view of the hermetic electronics control unit 20. The pad 23 facilitates attachment of wire 30, and is preferably comprised of a biocompatible material such as platinum, iridium, or alloys thereof, and is preferably comprised of platinum paste. Wire 30 is preferably bonded to pad 23 by welding. The microelectronics assembly 48 is mounted on the hybrid substrate 44. Vias 46 pass through the substrate 44 to input/output contacts 22. Electrical signals arrive by wire 30 and exit the electronics control unit 20 by input/output contacts 22.
  • A top view of the flexible circuit 18 is illustrated in FIG. 4. Electrical signals from the electronics control unit 20 (see FIG. 3) pass into bond pads 32, which are mounted in bond pad end 33. Flexible electrically insulating substrate 38 is preferably comprised of polyimide. The signals pass from the bond pads 32 along traces 34, which pass along flexible circuit ribbon 24 to the stimulating electrode array 10. The array 10 contains the electrodes 36, which are implanted to make electrical contact with the retina 14 of the eye 2, illustrated in FIG. 1. An alternative bed of nails embodiment for the electrodes 36 is disclosed by Byers, et al. in U.S. Pat. No. 4,837,049.
  • In FIG. 5, the hermetic electronics control unit 20 is illustrated mounted to flexible circuit 18. In order to assure electrical continuity between the electronics control unit 20 and the flexible circuit 18, the electrical control unit 20 must be intimately bonded to the flexible circuit 18 on the bond pad end 33. A cutaway of the electronics control unit 20 (FIG. 5) illustrates a bonded connection 42. The flexible electrically insulating substrate 38 is very thin and flexible and is able to conform to the curvature of the retina 14 (FIG. 1), when implanted thereon.
  • Methods of bonding the flexible insulating substrate 18 to the hermetic electronics control unit 20 are discussed next.
  • Platinum Conductor in Polymer Adhesive
  • A preferred embodiment of the invention, illustrated in FIG. 6, shows the method of bonding the hybrid substrate 244 to the flexible circuit 218 using electrically conductive adhesive 281, such as a polymer, which may include polystyrene, epoxy, or polyimide, which contains electrically conductive particulate of select biocompatible metal, such as platinum, iridium, titanium, platinum alloys, iridium alloys, or titanium alloys in dust, flake, or powder form.
  • In FIG. 6, step a, the hybrid substrate 244, which may alternatively be an integrated circuit or electronic array, and the input/output contacts 222 are prepared for bonding by placing conductive adhesive 281 on the input/output contacts 222. The rigid integrated circuit 244 is preferably comprised of a ceramic, such as alumina or silicon. In step b, the flexible circuit 218 is preferably prepared for bonding to the hybrid substrate 244 by placing conductive adhesive 281 on bond pads 232. Alternatively, the adhesive 281 may be coated with an electrically conductive biocompatible metal. The flexible circuit 218 contains the flexible electrically insulating substrate 238, which is preferably comprised of polyimide. The bond pads 232 are preferably comprised of an electrically conductive material that is biocompatible when implanted in living tissue, and are preferably platinum or a platinum alloy, such as platinum-iridium.
  • FIG. 6, step c illustrates the cross-sectional view A-A of step b. The conductive adhesive 281 is shown in contact with and resting on the bond pads 232. Step d shows the hybrid substrate 244 in position to be bonded to the flexible circuit 218. The conductive adhesive 281 provides an electrical path between the input/output contacts 222 and the bond pads 232. Step c illustrates the completed bonded assembly wherein the flexible circuit 218 is bonded to the hybrid substrate 144, thereby providing a path for electrical signals to pass to the living tissue from the electronics control unit (not illustrated). The assembly has been electrically isolated and hermetically sealed with adhesive underfill 280, which is preferably epoxy.
  • Studbump Bonding.
  • FIG. 7 illustrates the steps of an alternative embodiment to bond the hybrid substrate 244 to flexible circuit 218 by studbumping the hybrid substrate 244 and flexible electrically insulating substrate 238 prior to bonding the two components together by a combination of heat and/or pressure, such as ultrasonic energy. In step a, the hybrid substrate 244 is prepared for bonding by forming a studbump 260 on the input/output contacts 222. The studbump is formed by known methods and is preferably comprised of an electrically conductive material that is biocompatible when implanted in living tissue if exposed to a saline environment. It is preferably comprised of metal, preferably biocompatible metal, or gold or of gold alloys. If gold is selected, then it must be protected with a water resistant adhesive or underfill 280.
  • Alternatively, the studbump 260 may be comprised of an insulating material, such as an adhesive or a polymer, which is coated with an electrically conductive coating of a material that is biocompatible and stable when implanted in living tissue, while an electric current is passed through the studbump 260. One such material coating may preferably be platinum or alloys of platinum, such as platinum-iridium, where the coating may be deposited by vapor deposition, such as by ion-beam assisted deposition, or electrochemical means.
  • FIG. 7, step b presents the flexible circuit 218, which comprises the flexible electrically insulating substrate 238 and bond pads 232. The flexible circuit 218 is prepared for bonding by the plating bond pads 232 with an electrically conductive material that is biocompatible when implanted in living tissue, such as with a coating of platinum or a platinum alloy. Studbumps 260 are then formed on the plated pad 270 by known methods. Step c illustrates cross-section A-A of step b, wherein the flexible circuit 218 is ready to be mated with the hybrid substrate 244.
  • FIG. 7, step d illustrates the assembly of hybrid substrate 244 flipped and ready to be bonded to flexible circuit 218. Prior to bonding, the studbumps 260 on either side may be flattened by known techniques such as coining. Pressure is applied to urge the mated studbumps 260 together as heat is applied to cause the studbumps to bond by a diffusion or a melting process. The bond may preferably be achieved by thermosonic or thermocompression bonding, yielding a strong, electrically conductive bonded connection 242, as illustrated in step e. An example of a thermosonic bonding method is ultrasound. The bonded assembly is completed by placing an adhesive underfill 280 between the flexible circuit 218 and the hybrid substrate 244, also increasing the strength of the bonded assembly and electrically isolating each bonded connection. The adhesive underfill 280 is preferably epoxy.
  • Weld Staple Interconnect
  • FIG. 8 illustrates the steps of a further alternative embodiment to bond the hybrid substrate 44 to flexible circuit 18 by weld staple bonding the substrate 244 and flexible electrically insulating substrate 38 together. In step a, a top view of the flexible circuit 18 is shown. Flexible circuit 18 is comprised of flexible electrically insulating substrate 38, which is preferably polyimide, and bond pads 32 having a through hole 58 therethrough each bond pad 32 and through the top and bottom surfaces of flexible circuit 18. The bond pads 32 are comprised of an electrically conductive and biocompatible material which is stable when implanted in living tissue, and which is preferably platinum or a platinum alloy, such as platinum-iridium.
  • FIG. 8, step b presents section A-A, which is shown in the illustration of step a. The through holes 58 pass completely through each bond pad 58, preferably in the center of the bond pad 58. They are preferably formed by plasma etching. The bond pads 58 are not covered on the top surface of flexible circuit 18 by flexible electrically insulating substrate 38, thereby creating bond pad voids 56.
  • FIG. 8, step c shows the side view of hybrid substrate 44 with input/output contacts 22 on one surface thereof. The hybrid substrate 44 is positioned, in step d; to be bonded to the flexible circuit 18 by placing the parts together such that the input/output contacts 22 are aligned with the bond pads 32. Then wire 52, which is preferably a wire, but may equally well be a ribbon or sheet of weldable material that is also preferably electrically conductive and biocompatible when implanted in living tissue, is attached to input/output contact 22 and bond pad 32 to bond each aligned pair together. The wire 52 is preferably comprised of platinum, or alloys of platinum, such as platinum-iridium. The bond is preferably formed by welding using the parallel gap welder 50, which moves up and down to force the wire 52 into the through hole 58 and into contact with input/output contact 22. This process is repeated for each aligned set of input/output contacts 22 and bond pads 32, as shown in step e.
  • The weld staple interconnect bonding process is completed, as shown in step f, by cutting the wire 54, leaving each aligned set of input/output contacts 22 and bond pads 32 electrically connected and mechanically bonded together by staple 54.
  • Tail-Latch Interconnect
  • FIG. 9 illustrates yet another embodiment for attaching the hybrid substrate 244 to a flexible circuit 218 by using a tail-ball 282 component, as shown in step a. The hybrid substrate 244 is preferably comprised of a ceramic material, such as alumina or silicon. In one embodiment, a wire, preferably made of platinum or another electrically conductive, biocompatible material, is fabricated to have a ball on one end, like the preferred tail-ball 282 illustrated in step a. The tail-ball 282 has tail 284 attached thereto, as shown in the side view of step a. The tail-ball 282 is aligned with input/output contact 222 on hybrid substrate 244, in preparation to being bonded to flexible circuit 218, illustrated in step b.
  • The top view of step b illustrates flexible electrically insulating substrate 238, which is preferably comprised of polyimide, having the through hole 237 passing completely thorough the thickness and aligned with the tail 284. The bond pads 232 are exposed on both the top and bottom surfaces of the flexible circuit 218, by voids 234, enabling electrical contact to be made with input/output contacts 222 of the hybrid substrate 244. The voids are preferably formed by plasma etching.
  • The side view of FIG. 9, step c, which illustrates section A-A of step b, shows the hybrid substrate 244 in position to be bonded to and aligned with flexible circuit 218. The tails 284 are each placed in through hole 237. Pressure is applied and the tail-balls 282 are placed in intimate contact with bond pads 232 and input/output contacts 222. Step c illustrates that each of the tails 284 is bent to make contact with the bond pads 232. The bonding process is completed by bonding, preferably by welding, each of the tails 284, bond pads 232, tail-balls 282, and input/output contacts 222 together, thus forming a mechanical and electrical bond. Locking wire 262 is an optional addition to assure that physical contact is achieved in the bonded component. The process is completed by underfilling the gap with an electrically insulating and biocompatible material (not illustrated), such as epoxy.
  • Integrated Interconnect by Vapor Deposition
  • FIG. 10 illustrates a further alternative embodiment to creating a flexible circuit that is electrically and adhesively bonded to a hermetic rigid electronics package. In this approach, the flexible circuit is fabricated directly on the rigid substrate. Step a shows the hybrid substrate 44, which is preferably a ceramic, such as alumina or silicon, having a total thickness of about 0.012 inches, with patterned vias 46 therethrough. The vias 46 are preferably comprised of frit containing platinum.
  • In step b, the routing 35 is patterned on one side of the hybrid substrate 44 by known techniques, such as photolithography or masked deposition. It is equally possible to form routing 35 on both sides of the substrate 44. The hybrid substrate 44 has an inside surface 45 and an outside surface 49. The routing 35 will carry electrical signals from the integrated circuit, that is to be added, to the vias 46, and ultimately will stimulate the retina (not illustrated). The routing 35 is patterned by know processes, such as by masking during deposition or by post-deposition photolithography. The routing 35 is comprised of a biocompatible, electrically conductive, patternable material, such at platinum.
  • Step c illustrates formation of the release coat 47 on the outside surface 49 of the hybrid substrate 44. The release coat 47 is deposited by known techniques, such as physical vapor deposition. The release coat 47 is removable by know processes such as etching. It is preferably comprised of an etchable material, such as aluminum.
  • Step d illustrates the formation of the traces 34 on the outside surface 49 of the hybrid substrate 44. The traces 34 are deposited by a known process, such as physical vapor deposition or ion-beam assisted deposition. They may be patterned by a known process, such as by masking during deposition or by post-deposition photolithography. The traces 34 are comprised of an electrically conductive, biocompatible material, such as platinum, platinum alloys, such as platinum-iridium, or titanium-platinum. The traces 34 conduct electrical signals along the flexible circuit 18 and to the stimulating electrode array 10, which were previously discussed and are illustrated in FIG. 4.
  • Step e illustrates formation of the flexible electrically insulating substrate 38 by known techniques, preferably liquid precursor spinning. The flexible electrically insulating substrate 38 is preferably comprised of polyimide. The flexible electrically insulating substrate electrically insulates the traces 34. It is also biocompatible when implanted in living tissue. The coating is about 5 um thick. The liquid precursor is spun coated over the traces 34 and the entire outside surface 49 of the hybrid substrate 44, thereby forming the flexible electrically insulating substrate 38. The spun coating is cured by known techniques.
  • Step f illustrates the formation of voids in the flexible electrically insulating substrate 38 thereby revealing the traces 34. The flexible electrically insulating substrate is preferably patterned by known techniques, such as photolithography with etching.
  • Step g illustrates the rivets 51 having been formed over and in intimate contact with traces 34. The rivets 51 are formed by known processes, and are preferably formed by electrochemical deposition of a biocompatible, electrically conductive material, such as platinum or platinum alloys, such as platinum-iridium.
  • Step h illustrates formation of the metal layer 53 over the rivets 51 in a controlled pattern, preferably by photolithographic methods, on the outside surface 49. The rivets 51 and the metal layer 53 are in intimate electrical contact. The metal layer 53 may be deposited by known techniques, such as physical vapor deposition, over the entire surface followed by photolithographic patterning, or it may be deposited by masked deposition. The metal layer 53 is formed of an electrically conductive, biocompatible material, which in a preferred embodiment is platinum. The patterned metal layer 53 forms traces 34 and electrodes 36, which conduct electrical signals from the electronics control unit 20 and the electrodes 36 (see FIGS. 4 and 5).
  • Step i illustrates the flexible electrically insulating substrate 38 applied over the outside surface 49 of the rigid substrate 44, as in step e. The flexible electrically insulating substrate 38 covers the rivets 51 and the metal layer 53.
  • Step j illustrates the hybrid substrate 44 having been cut by known means, preferably by a laser or, in an alternative embodiment, by a diamond wheel, thereby creating cut 55. The portion of hybrid substrate 44 that will be removed is called the carrier 60.
  • The flexible electrically insulating substrate 38 is patterned by known methods, such as photolithographic patterning, or it may be deposited by masked deposition, to yield voids that define the electrodes 36. The electrodes 36 transmit electrical signals directly to the retina of the implanted eye (see FIG. 4)
  • Step k illustrates flexible circuit 18 attached to the hybrid substrate 44. The carrier 60 is removed by utilizing release coat 47. In a preferred embodiment, release coat 47 is etched by known means to release carrier 60, leaving behind flexible circuit 18.
  • Step l illustrates the implantable electronic device of a flexible circuit 18 and an intimately bonded hermetic electronics control unit 20. The electronics control unit 20, which contains the microelectronics assembly 48, is hermetically sealed with header 62 bonded to rigid circuit substrate 44. The header 62 is comprised of a material that is biocompatible when implanted in living tissue and that is capable of being hermetically sealed to protect the integrated circuit electronics from the environment.
  • FIG. 11 illustrates an electronics control unit 320 attached to flexible electrically insulating substrate 338, which is preferably comprised of polyimide, by bonded connections 342. The electronics control unit 320 is preferably a hermetically sealed integrated circuit, although in an alternative embodiment it may be a hermetically sealed hybrid assembly. Bonded connections 342 are preferably conductive adhesive, although they may alternatively be solder bumps. The bond area is underfilled with an adhesive 380. Rigid stimulating electrode array 310 is attached to the flexible electrically insulating substrate 338 by bonded connections 342.
  • FIG. 12 illustrates an electronics control unit 320 attached to rigid stimulating electrode array 310 by bonded connections 342. The bond area is then underfilled with an adhesive 380, preferably epoxy. Bonded connections 342 are preferably conductive adhesive, although they may alternatively be solder bumps.
  • The bonding steps are illustrated in FIG. 13 for a flex circuit assembly that is bonded with rivets 61 that are created in situ by a deposition process, preferably by electroplating. The rivets 61 are rivet-shaped electrical connections. The substrate 68 is shown generally in FIG. 13. It is comprised of the hybrid substrate 44, which is preferably a ceramic, such as alumina or silicon. The silicon would preferably be coated with a biocompatible material to achieve biocompatibility of the silicon, which is well known to slowly dissolve when implanted in living tissue.
  • The hybrid substrate 44 preferably contains vias 46 that pass through the thickness of the hybrid substrate 44, see FIG. 13, step (a). Vias 46 are not required to enable this invention, and are not present in alternative embodiments. It is preferred that the hybrid substrate 44 be rigid, although alternative embodiments utilize a non-rigid substrate. The vias 46 are integral with electrically conductive routing 35 that has been placed on the surface of the hybrid substrate 44 by known techniques. The routing is preferably comprised of a stable biocompatible material, such as platinum, a platinum alloy, or gold, most preferably platinum.
  • A flexible electrically insulating substrate 38 is preferably comprised of two layers of an electrically insulating material, such as a polymer. Known preferred polymer materials are polyimide or Parylene. Parylene refers to polyparaxylylene, a known polymer that has excellent implant characteristics. For example, Parylene, manufactured by Specialty Coating Systems (SCS), a division of Cookson Electronic Equipment Group, located in Indianapolis, Ind., is a preferred material. Parylene is available in various forms, such as Parylene C, Parylene D, and Parylene N, each having different properties. The preferred form is Parylene C.
  • The flexible electrically insulating substrate layers 38 are preferably of approximately equal thicknesses, as illustrated in FIG. 13, step (a). A trace 65 is also illustrated in FIG. 13, step (a), where trace 65 may be at least one, but preferably more than one, trace 65 that is electrically conductive. The traces 65 are integrally bonded to bond pads 63. The bond pads 63 each have a bond pad hole 64 therethrough, which is in approximate alignment with first hole 57 in first electrically insulating substrate 37 and second hole 59 in the second flexible electrically insulating substrates 38, such that there is a hole, with centers approximately aligned, through the thickness of the flexible assembly 66.
  • The flexible assembly 66 is placed next to the hybrid substrate in preparation for bonding, FIG. 13, step (b). The flexible assembly aligned holes that are formed by first substrate holes 57, bond pad holes 64, and second substrate holes 59 are aligned with the routing 35. In a preferred embodiment, there is at least one via 46, although no via 46 is required. In a preferred embodiment, an adhesive layer 39 is applied to adhesively bond the assembly together. The adhesive is preferably epoxy, silicone, or polyimide. In alternative embodiments, the assembly is not adhesively bonded.
  • As illustrated in FIG. 13, step (c), a rivet 61 is formed in each flexible substrate hole to bond the assembly together. The rivets 61 are preferably formed by a deposition process, most preferably electroplating. The rivets 61 are comprised of a biocompatible, electrically conductive material, preferably platinum, although alternative embodiments may utilize platinum alloys (e.g. platinum-iridium or platinum-rhodium), iridium, gold, palladium, or palladium alloys. It is most preferred that rivet 61 be comprised of electroplated platinum, called “plated platinum” herein.
  • Referring to FIGS. 14 and 15, a method to produce plated platinum according to the present invention is described comprising connecting a common electrode 402, the anode, and a bonded assembly 70, the cathode, to a voltage to current converter 406 with a wave form generator 430 and monitor 428, preferably an oscilloscope. The common electrode 402, bonded assembly 70, a reference electrode 410, for use as a reference in controlling the power source, which is comprised of a voltage to current converter 406 and a waveform generator 430, and an electroplating solution are placed in a electroplating cell 400 having a means for mixing 414 the electroplating solution. Power may be supplied to the electrodes with constant voltage, constant current, pulsed voltage, scanned voltage or pulsed current to drive the electroplating process. The waveform generator 430 and voltage to current converter 406 is set such that the rate of deposition will cause the platinum to deposit as plated platinum, the rate being greater than the deposition rate necessary to form shiny platinum and less than the deposition rate necessary to form platinum black.
  • Because no impurities or other additives, such as lead, which is a neurotoxin and cannot be used in an implantable device, need to be introduced during the plating process to produce plated platinum, the plated material can be pure platinum. Alternatively, other materials can be introduced during the plating process, if so desired, but these materials are not necessary to the formation of plated platinum.
  • Referring to FIGS. 14 and 15, the electroplating cell 400, is preferably a 50 ml to 150 ml four neck glass flask or beaker, the common electrode 402, or anode, is preferably a large surface area platinum wire or platinum sheet, the reference electrode 410 is preferably a Ag/AgCl electrode (silver, silver chloride electrode), the bonded assembly 70, or cathode, can be any suitable material depending on the application and can be readily chosen by one skilled in the art. Preferable examples of the bonded assembly 70 include, but are not limited to, platinum, iridium, rhodium, gold, tantalum, titanium or niobium, preferably platinum.
  • The means for mixing 414 is preferably a magnetic stirrer (FIG. 15). The plating solution is preferably 3 to 30 millimoles ammonium hexachloroplatinate in 0.4 moles of disodium hydrogen phosphate, but may be derived from any chloroplatinic acid or bromoplatinic acid or other electroplating solution. The preferable plating temperature is approximately 24′-26° C.
  • The electroplating system for pulsed current control is shown in FIGS. 14 and 15. While constant voltage, constant current, pulsed voltage or pulsed current can be used to control the electroplating process, pulsed current control of the plating process is preferable for plating rivets 61, which have a height that approximates their diameter. The preferable current range to produce plated platinum, which varies from about 50 to 2000 mA/cm2, is dependent on the whole dimensions, FIG. 16, where the response voltage ranges from about −0.45 volts to −0.85 volts. Applying power in this range with the above solution yields a plating rate in the range of about 0.05 um per minute to 1.0 um per minute, the preferred range for the plating rate of plated platinum. The average current density may be determined by the equation y=19572x−1.46, where y is the average current density in mA/cm2 and x is the hole diameter in microns. Pulsed current control also allows an array of rivets to be plated simultaneously achieving uniform rivet properties.
  • As plating conditions, including but not limited to the plating solution, surface area of the electrodes, pH, platinum concentration and the presence of additives, are changed the optimal control parameters will change according to basic electroplating principles. Plated platinum will be formed so long as the rate of deposition of the platinum particles is slower than that for the formation of platinum gray and faster than that for the formation of shiny platinum.
  • It has been found that because of the physical strength of plated platinum, it is possible to plate rivets of thickness greater than 30 microns. It is very difficult to plate shiny platinum in layers greater than approximately several microns because the internal stress of the dense platinum layer cause the plated layer to peel off.
  • On a hybrid substrate 44, a thin-layer routing 35, preferably platinum, is sputtered and then covered with about 6 um thick flexible assembly 66, preferably polyimide, with holes in the range from 5 um to 50 um. On each sample, preferably about 100 to 700 or more such holes are exposed for plating of rivets 61, see FIG. 17 a.
  • SEM micrographs record the rivet surface appearance before plating. The surface is chemically and electrochemically cleaned before plating.
  • The electrodes in the test cell are arranged, so that the bonded assembly 70 (cathode) is physically parallel with the common electrode 402 (anode). The reference electrode 410 is positioned beside the bonded assembly 70. The plating solution is added to electroplating solution level 411. The solution is comprised of about 18 millimoles ammonium hexachloroplatinate in about 0.4 moles phosphate buffer solution. The amount of solution used depends on the number of rivets 61 to be plated. The means for mixing 414, preferably a magnetic stirrer, is activated.
  • A voltage waveform is generated, preferably with a 1 msec pulse width as a 500 Hz square wave, which is converted to a current signal through a voltage to current converter 406.
  • The pulse current is applied to the plating electrode versus anode. The electrode voltage versus Ag/AgCl reference electrode is monitored using an oscilloscope (Tektronix TDS220 Oscilloscope). The current amplitude is adjusted so that the cathodic peak voltage reaches about −0.6 v versus the Ag/AgCl reference electrode 410. During plating, the electrode voltage tends to decrease with plating time. The current amplitude is frequently adjusted so that the electrode voltage is kept within −0.5 to −0.7 v range versus Ag/AgCl reference electrode 410. When the specified plating time is reached, he current is eliminated. The cathode is rinsed in deionized water thoroughly. Typical plating time is in the range of about 5 to 60 minutes, preferably 15 to 25 minutes.
  • The plated surface is examined under an optical microscope. Optical photomicrographs are taken at both low and high magnifications to record the image of the surface. The plated samples are profiled with a surface profilometer to measure the dimensions of the plated rivet. The total plated rivet has a total height of about 8 to 16 um.
  • After plating, the pulsing current amplitudes are averaged for the total plating time and recorded. It is has been demonstrated that the current density increases exponentially with sample hole decrease. The smaller the sample holes, the higher the current density required (see FIG. 16).
  • An illustrative example of a plated platinum rivet according to the present invention are micrographs produced on a Scanning Electron Microscope (SEM) at 850× taken by a JEOL JSM5910 microscope, FIGS. 17 a and 17 b.
  • A further preferred embodiment of the invention, illustrated in FIG. 18, shows the method of bonding the hybrid substrate 244 to the flexible circuit 218 using electrically conductive adhesive 281, such as a polymer, which may include polystyrene, epoxy, or polyimide, which contains electrically conductive particulate of select biocompatible metal, such as platinum, iridium, titanium, platinum alloys, iridium alloys, or titanium alloys in dust, flake, or powder form.
  • In FIG. 18, step a, the hybrid substrate 244, which may alternatively be an integrated circuit or electronic array, and the input/output contacts 222 are prepared for bonding by placing conductive adhesive 281 on the input/output contacts 222. The conductive adhesive 281, which includes at least one bump, is cured to become hard. A second conductive adhesive 281 a is applied on top of the first cured conductive adhesive 281. Preferably on each bump of conductive adhesive 281 an additional bump is applied to raise the bumps of conductive adhesive. The rigid integrated circuit 244 is preferably comprised of a ceramic, such as alumina or silicon. In step b, the flexible circuit 218 is preferably prepared for bonding to the hybrid substrate 244 by placing conductive adhesive 281 on bond pads 232. Alternatively, the adhesive 281 may be coated with an electrically conductive biocompatible metal. The flexible circuit 218 contains the flexible electrically insulating substrate 238, which is preferably comprised of polyimide. The bond pads 232 are preferably comprised of an electrically conductive material that is biocompatible when implanted in living tissue, and are preferably platinum or a platinum alloy, such as platinum-iridium.
  • FIG. 18, step c illustrates the cross-sectional view A-A of step b. The conductive adhesive 281 is shown in contact with and resting on the bond pads 232. Step d shows the hybrid substrate 244 in position being bonded to the flexible circuit 218. The conductive adhesive 281 resting on the bond pads 232 and the conductive adhesive 281 a resting on the cured conductive adhesive 281 resting on the contacts 222, are cured to yield one conductive adhesive 281/281 a/281. The conductive adhesive 281/281 a/281 provides an electrical path between the input/output contacts 222 and the bond pads 232. Step c illustrates the completed bonded assembly wherein the flexible circuit 218 is bonded to the hybrid substrate 244, thereby providing a path for electrical signals to pass to the living tissue from the electronics control unit (not illustrated). The conductive adhesive 281/281 a/281 is higher than in the embodiment shown in FIG. 6 and the distance between the hybrid substrate 244 and flexible circuit 218 is larger. In step e the assembly has been electrically isolated and hermetically sealed with adhesive underfill 280, which is preferably epoxy. Since the distance between the hybrid substrate 244 and flexible circuit 218 is larger the underfill 280 is higher in this embodiment.
  • The method of manufacturing an implantable electronic device comprises the following steps:
  • a) applying conductive adhesive 281 on one or more contacts 222 on a substrate 244, and curing the conductive adhesive 281;
  • b) applying one or more layers of conductive adhesive 281 a on the cured conductive adhesive 281;
  • c) applying conductive adhesive 281 on one or more bond pads 232 on a flexible assembly 218;
  • d) aligning the contacts 222 on the substrate with the bond pads 232 on the flexible assembly;
  • e) curing the conductive adhesive 281 connecting the contacts 232 on the substrate 244 with the bond pads 232 on the flexible assembly 218; and
  • f) filling the remaining space between the substrate and the flexible assembly with adhesive underfill 280, and curing the underfill 280.
  • Each layer of conductive adhesive applied on the substrate is preferably cured prior to aligning with the conductive adhesive applied on the flexible assembly. A biocompatible non-conductive adhesive underfill is preferably applied between the substrate and the flexible assembly.
  • The adhesive connecting the contacts on the substrate with the bond pads on the flexible assembly contains epoxy or polyimide filled with electrically conductive biocompatible metal in dust, flake, or powder form. The electrically conductive biocompatible metal preferably comprises silver, gold, platinum, iridium, titanium, platinum alloys, iridium alloys, titanium alloys in, or mixtures thereof. The adhesive connecting the contacts on the substrate with the bond pads on the flexible assembly can alternatively be coated with an electrically conductive biocompatible metal.
  • The adhesive underfill is cured at a pressure of 50 PSI to 100 PSI. The adhesive underfill is preferably cured at a pressure of 60 PSI to 90 PSI. The adhesive underfill is more preferably cured at a pressure of 70 PSI to 85 PSI. The curing process carried out under pressure yields an adhesive with very limited amount of gas bubbles and improved adhesion. The adhesive underfill is cured under pressure at a temperature of 20° C. to 30° C. for 3 h to 50 h. The adhesive underfill is alternatively cured at a temperature of 70° C. to 100° C. for a time of 10 min to 2 h.
  • The height of one or more conductive adhesives on the substrate determines the distance between the substrate and the flexible assembly. The conductive adhesive on the substrate which comprises one or more layer and is preferably in the form of bumps is preferably cured before being aligned with the uncured bumps on the flexible assembly. The hard bumps of conductive adhesives on the substrate push into the soft bumps of the flexible assembly as deep as possible prior to the final curing process. Therefore, the higher the hard bumps on the substrate are the larger is the distance between the substrate and the flexible assembly. The implantable electronic device comprises:
  • a) a substrate 244 having one or more contacts 222 and two or more layers of conductive adhesive 281/281 a on the contacts 222;
  • b) a flexible assembly 218 having one or more bond pads 232 and one or more layers of conductive adhesive 281 on the bond pads 232;
  • c) the conductive adhesive 281 connecting the contacts 222 on the substrate 244 with the bond pads 232 on the flexible assembly 218; and
  • d) adhesive underfill 280 in the remaining space between the substrate 244 and the flexible assembly 218.
  • The substrate comprises a biocompatible ceramic. The biocompatible ceramic comprises alumina. The substrate is rigid and is an electrically insulated substrate circuit. The flexible assembly is a thin substrate circuit. The conductive adhesive provides an electrical path between the input/output contacts and the bond pads. The adhesive underfill is nonconductive and contains epoxy.
  • Furthermore, it has been found that because of the physical strength of plated platinum, it is possible to plate rivets 61 of thickness greater than 16 um. It is very difficult to plate shiny platinum in layers greater than approximately 1 to 5 um because the internal stress of the dense platinum layer which will cause plated layer to peel off.
  • The following example is illustrative of electroplating platinum as a rivet 61, according to the present invention.
  • EXAMPLE
  • A flexible electrically insulating substrate comprised of a first substrate 37 and a second substrate 38 of polyimide having a total thickness of 6 um. It had 700 first substrate holes 57, an equal number of matching bond pad holes 64, and an equal number of matching second substrate holes 59, all in alignment so as to create a continuous hole through flexible assembly 66 that terminates on routing 35, arranged in 100 groups of seven on about 40 um centers, FIG. 4 a. The hybrid substrate 44 was alumina and the routing 35 was platinum. The bond pad 63 was platinum.
  • The assembly was cleaned by rinsing three times in 10% HCl. It was further prepared by bubbling for 10 seconds at +/−5V at 1 Hz in phosphate buffered saline. Finally, it was rinsed in deionized water.
  • The electroplating set up according to FIGS. 14 and 15 was comprised of an electroplating cell 400 that was a 100 ml beaker with an electroplating solution level 411 at about the 75 ml level. The solution was 18 millimoles of ammonium hexachloroplatinate in 0.4 moles phosphate buffer solution.
  • The means for mixing 414 was a magnetic stirrer, which was activated. The voltage waveform of 1 msec pulse width as a square wave was generated by an HP 33120A waveform generator, which is converted to current signal through a voltage to current converter 406. The pulse current was 1 msec in pulse width at 500 Hz square wave.
  • The pulse current was applied on the plating electrode bonded assembly 70 versus common electrode 402. The electrode voltage versus Ag/AgCl reference electrode 410 was monitored using as a monitor 428 a Tektronix model TDS220 oscilloscope. The current amplitude was increased so that the bonded assembly 70 (cathode) peak voltage reached −0.6 v versus the Ag/AgCl reference electrode 410. During plating, the electrode voltage decreased with plating time.
  • The average current density was 660 mA/cm2, which generated response voltages of −0.5 to −0.7 volts, where the voltage was controlled by the current. A 1 msec pulse width square wave was generated by an HP 33120A Arbitrary Waveform Generator. The pulse was converted to a current signal through a voltage to current converter 406. The pulse current was typically about 1 msec in pulse width as a 500 Hz square wave. The resulting plated platinum rivet 61 was about 32 um diameter on the button end and about 15 um tall, with about 9 um of the height extending above the polyimide substrate. The plated platinum rivet was dense, strong, and electrically conductive.
  • Scanning Electron Microscope (SEM)/energy dispersive analysis (EDAX™) analysis were performed on the rivets 61. SEM micrographs of the plated surface were taken showing its as-plated surface, FIG. 17 b. Energy dispersed analysis demonstrated that the rivet 61 was pure platinum, with no detectable oxygen.
  • The above described is the preferred embodiment of the current invention, however the platinum electrodeposition described in co-pending application “Platinum Electrode and Method for Manufacturing the Same,” Application No. 10/226,976, filed on Aug. 23, 2002, now U.S. Pat. No. 6,974,533, and incorporated herein by reference, is also effective for forming electrochemically deposited rivets.
  • The rivet 61 (FIG. 13) forms an electrically conductive bond with the routing 35 and with the bond pad 63. It is obvious that the bonded assembly may be stacked with other bonded assemblies forming multiple stacked assemblies with increased stacking density.
  • Accordingly, what has been shown is an improved flexible circuit with an electronics control unit attached thereto, which is suitable for implantation in living tissue and to transmit electrical impulses to the living tissue. Obviously, many modifications and variations of the present invention are possible in light of the above teachings. It is therefore to be understood that, within the scope of the appended claims, the invention may be practiced other than as specifically described.

Claims (34)

1. A method of manufacturing an implantable electronic device, comprising:
a) applying conductive adhesive on one or more contacts on a substrate, and curing said conductive adhesive;
b) applying one or more layers of conductive adhesive on said cured conductive adhesive;
c) applying conductive adhesive on one or more bond pads on a flexible assembly;
d) aligning said conductive adhesive on said substrate with said conductive adhesive on said flexible assembly;
e) curing said conductive adhesive connecting said contacts on said substrate with said bond pads on said flexible assembly; and
f) filling the remaining space between said substrate and said flexible assembly with adhesive underfill, and curing said underfill.
2. The method according to claim 1 wherein each layer of conductive adhesive applied on said substrate is cured prior to aligning.
3. The method according to claim 1 wherein said conductive adhesive on said substrate and said conductive adhesive on said flexible assembly is applied as at least one bump.
4. The method according to claim 1 wherein at least one bump of said conductive adhesive on said substrate is aligned with at least one bump of said conductive adhesive on said flexible assembly.
5. The method according to claim 1 wherein a biocompatible adhesive underfill is applied between said substrate and said flexible assembly.
6. The method according to claim 1 wherein an electrically non-conductive adhesive underfill is applied between said substrate and said flexible assembly.
7. The method according to claim 1 wherein said adhesive connecting said contacts on said substrate with said bond pads on said flexible assembly contains epoxy or polyimide filled with electrically conductive biocompatible metal in dust, flake, or powder form.
8. The method according to claim 7 wherein said electrically conductive biocompatible metal comprises silver, gold, platinum, iridium, titanium, platinum alloys, iridium alloys, titanium alloys in, or mixtures thereof.
9. The method according to claim 1 wherein said adhesive connecting said contacts on said substrate with said bond pads on said flexible assembly is coated with an electrically conductive biocompatible metal.
10. The method according to claim 9 wherein said electrically conductive biocompatible metal comprises silver, gold, platinum, iridium, titanium, platinum alloys, iridium alloys, titanium alloys in, or mixtures thereof.
11. The method according to claim 1 wherein the adhesive underfill is cured at a pressure of 50 PSI to 100 PSI.
12. The method according to claim 11 wherein the adhesive underfill is cured at a pressure of 60 PSI to 90 PSI.
13. The method according to claim 11 wherein the adhesive underfill is cured at a pressure of 70 PSI to 85 PSI.
14. The method according to claim 11 wherein the adhesive underfill is cured at a temperature of 20° C. to 30° C.
15. The method according to claim 14 wherein the adhesive underfill is cured for a time of 3 h to 50 h.
16. The method according to claim 11 wherein the adhesive underfill is cured at a temperature of 70° C. to 100° C.
17. The method according to claim 16 wherein the adhesive underfill is cured for a time of 10 min to 2 h.
18. The method according to claim 1 wherein the height of one or more conductive adhesives on said substrate determine the distance between said substrate and said flexible assembly.
19. The method according to claim 1 wherein said conductive adhesive is applied to said substrate and/or to said flexible assembly by pencil printing.
20. The method according to claim 1 wherein said conductive adhesive is applied to said substrate and/or to said flexible assembly by screen printing.
21. The method according to claim 1 wherein said conductive adhesive is applied to said substrate and/or to said flexible assembly by needle dispense.
22. The method according to claim 1 wherein said conductive adhesive is applied to said substrate and/or to said flexible assembly by jet dispense.
23. The method according to claim 1 wherein said conductive adhesive is applied to said substrate and/or to said flexible assembly by pin dip dispense.
24. An implantable electronic device obtained by the method of claim 1.
25. An implantable electronic device, comprising:
a) a substrate having one or more contacts and two or more layers of conductive adhesive on said contacts;
b) a flexible assembly having one or more bond pads and one or more layers of conductive adhesive on said bond pads;
c) said conductive adhesive connecting said contacts on said substrate with said bond pads on said flexible assembly; and
d) adhesive underfill in the remaining space between said substrate and said flexible assembly.
26. e device according to claim 25 wherein said flexible assembly comprises polyimide.
27. The device according to claim 25 wherein said substrate comprises a biocompatible ceramic.
28. The device according to claim 25 wherein said biocompatible ceramic comprises alumina.
29. The device according to claim 25 wherein said substrate is rigid.
30. The device according to claim 25 wherein said substrate is an electrically insulated substrate circuit.
31. The device according to claim 25 wherein said flexible assembly is a thin substrate circuit.
32. The method according to claim 25 wherein said conductive adhesive provides an electrical path between said input/output contacts and said bond pads.
33. The method according to claim 25 wherein said adhesive underfill is nonconductive.
34. The method according to claim 25 wherein said adhesive underfill contains epoxy.
US11/517,859 2002-04-11 2006-09-07 Biocompatible bonding method and electronics package suitable for implantation Expired - Lifetime US7645262B2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US11/517,859 US7645262B2 (en) 2002-04-11 2006-09-07 Biocompatible bonding method and electronics package suitable for implantation
PCT/US2007/004741 WO2007106318A2 (en) 2006-03-03 2007-02-22 Biocompatible bonding method and electronics package suitable for implantation
US11/928,515 US7835794B2 (en) 2002-04-11 2007-10-30 Electronics package suitable for implantation
US12/899,451 US8165680B2 (en) 2002-04-11 2010-10-06 Electronics package suitable form implantation
US13/429,215 US8285380B2 (en) 2002-04-11 2012-03-23 Electronics package suitable for implantation
US13/610,653 US8644937B2 (en) 2002-04-11 2012-09-11 Electronics package suitable for implantation

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US37206202P 2002-04-11 2002-04-11
US10/174,349 US7211103B2 (en) 2002-04-11 2002-06-17 Biocompatible bonding method and electronics package suitable for implantation
US10/236,396 US7142909B2 (en) 2002-04-11 2002-09-06 Biocompatible bonding method and electronics package suitable for implantation
US77883306P 2006-03-03 2006-03-03
US11/517,859 US7645262B2 (en) 2002-04-11 2006-09-07 Biocompatible bonding method and electronics package suitable for implantation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/236,396 Continuation-In-Part US7142909B2 (en) 2002-04-11 2002-09-06 Biocompatible bonding method and electronics package suitable for implantation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/928,515 Division US7835794B2 (en) 2002-04-11 2007-10-30 Electronics package suitable for implantation

Publications (2)

Publication Number Publication Date
US20070207569A1 true US20070207569A1 (en) 2007-09-06
US7645262B2 US7645262B2 (en) 2010-01-12

Family

ID=38229822

Family Applications (5)

Application Number Title Priority Date Filing Date
US11/517,859 Expired - Lifetime US7645262B2 (en) 2002-04-11 2006-09-07 Biocompatible bonding method and electronics package suitable for implantation
US11/928,515 Expired - Lifetime US7835794B2 (en) 2002-04-11 2007-10-30 Electronics package suitable for implantation
US12/899,451 Expired - Lifetime US8165680B2 (en) 2002-04-11 2010-10-06 Electronics package suitable form implantation
US13/429,215 Expired - Fee Related US8285380B2 (en) 2002-04-11 2012-03-23 Electronics package suitable for implantation
US13/610,653 Expired - Lifetime US8644937B2 (en) 2002-04-11 2012-09-11 Electronics package suitable for implantation

Family Applications After (4)

Application Number Title Priority Date Filing Date
US11/928,515 Expired - Lifetime US7835794B2 (en) 2002-04-11 2007-10-30 Electronics package suitable for implantation
US12/899,451 Expired - Lifetime US8165680B2 (en) 2002-04-11 2010-10-06 Electronics package suitable form implantation
US13/429,215 Expired - Fee Related US8285380B2 (en) 2002-04-11 2012-03-23 Electronics package suitable for implantation
US13/610,653 Expired - Lifetime US8644937B2 (en) 2002-04-11 2012-09-11 Electronics package suitable for implantation

Country Status (2)

Country Link
US (5) US7645262B2 (en)
WO (1) WO2007106318A2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080048316A1 (en) * 2006-08-25 2008-02-28 Micron Technology, Inc. Packaged microdevices and methods for manufacturing packaged microdevices
US20110089041A1 (en) * 2009-10-19 2011-04-21 Biomet Manufacturing Corp. Methods of depositing discrete hydroxyapatite regions on medical implants
WO2011072128A1 (en) * 2009-12-11 2011-06-16 Stryker Corporation Implantable electrode array assembly with electrodes that are integral with the asics that source/sink current to the electrodes
WO2011137298A3 (en) * 2010-04-30 2011-12-22 Second Sight Medical Products,Inc. Improved biocompatible bonding method
WO2012015756A2 (en) * 2010-07-29 2012-02-02 Proteus Biomedical, Inc. Hybrid housing for implantable medical device
US20120231585A1 (en) * 2009-06-29 2012-09-13 Hon Hai Precision Industry Co., Ltd. Method for packaging a semiconductor structure
US20130017367A1 (en) * 2010-03-30 2013-01-17 Wise S.R.L. Method for the production of functionalized elastomeric manufactured articles and manufactured articles thus obtained
US8386047B2 (en) 2010-07-15 2013-02-26 Advanced Bionics Implantable hermetic feedthrough
WO2013048396A1 (en) * 2011-09-28 2013-04-04 Advanced Bionics Ag Modular biomedical implants
US8552311B2 (en) 2010-07-15 2013-10-08 Advanced Bionics Electrical feedthrough assembly
WO2014108266A1 (en) * 2013-01-11 2014-07-17 Retina Implant Ag Device for the contacting and/or electrostimulation of biological tissue
NL2013213B1 (en) * 2014-07-18 2016-07-14 Sapiens Steering Brain Stimulation Bv An electrical connection assembly for a medical implant and a method of providing an electrical connection between a thin film and a connector for a medical implant.
US9770582B2 (en) 2009-08-05 2017-09-26 Stryker Corporation Implantable electrode array assembly including a carrier with embedded control modules contained in packages, the packages extending outwardly so as to extend over the carrier
WO2019036210A1 (en) * 2017-08-15 2019-02-21 Verily Life Sciences Llc Hybrid neurostimulation lead combining flexible circuit electrodes with lead body having bulk conductor
US11116964B2 (en) 2016-11-07 2021-09-14 Micro-Leads, Inc. Multi-electrode array with unitary body
US11395924B2 (en) 2019-01-07 2022-07-26 Micro-Leads, Inc. Implantable devices with welded multi-contact electrodes and continuous conductive elements

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US7877866B1 (en) * 2005-10-26 2011-02-01 Second Sight Medical Products, Inc. Flexible circuit electrode array and method of manufacturing the same
WO2008112578A1 (en) 2007-03-09 2008-09-18 Proteus Biomedical, Inc. In-body device having a deployable antenna
US8007726B2 (en) * 2007-06-04 2011-08-30 Chung Hua University Microarray bioprobe device integrated with an amplifier having bottom-gate thin film transistors
AU2009281876B2 (en) 2008-08-13 2014-05-22 Proteus Digital Health, Inc. Ingestible circuitry
WO2010035173A1 (en) * 2008-09-29 2010-04-01 Nxp B.V. Visual prosthesis implant
US8505805B2 (en) * 2008-10-09 2013-08-13 Honeywell International Inc. Systems and methods for platinum ball bonding
US7898074B2 (en) * 2008-12-12 2011-03-01 Helmut Eckhardt Electronic devices including flexible electrical circuits and related methods
KR101088806B1 (en) 2009-01-07 2011-12-01 주식회사 뉴로바이오시스 Micro-electrode Array Package using Liquid Crystal Polymer and Manufacturing Method thereof
US8150526B2 (en) 2009-02-09 2012-04-03 Nano-Retina, Inc. Retinal prosthesis
US8428740B2 (en) 2010-08-06 2013-04-23 Nano-Retina, Inc. Retinal prosthesis techniques
US8718784B2 (en) 2010-01-14 2014-05-06 Nano-Retina, Inc. Penetrating electrodes for retinal stimulation
US8706243B2 (en) 2009-02-09 2014-04-22 Rainbow Medical Ltd. Retinal prosthesis techniques
US8442641B2 (en) 2010-08-06 2013-05-14 Nano-Retina, Inc. Retinal prosthesis techniques
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
SG10201810784SA (en) 2009-04-28 2018-12-28 Proteus Digital Health Inc Highly Reliable Ingestible Event Markers And Methods For Using The Same
EP2432458A4 (en) 2009-05-12 2014-02-12 Proteus Digital Health Inc Ingestible event markers comprising an ingestible component
US8859696B2 (en) 2009-10-19 2014-10-14 Sasol Technology (Pty) Limited Oligomerisation of olefinic compounds with reduced polymer formation
BR112012025650A2 (en) 2010-04-07 2020-08-18 Proteus Digital Health, Inc. miniature ingestible device
WO2011155946A1 (en) * 2010-06-11 2011-12-15 Premitec, Inc. Flexible electronic devices and related methods
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
CN103313754B (en) 2010-11-16 2015-09-30 小利兰·斯坦福大学理事会 Be used for the treatment of the system and method for xerophthalmia
EP2642983A4 (en) 2010-11-22 2014-03-12 Proteus Digital Health Inc Ingestible device with pharmaceutical product
US8571669B2 (en) 2011-02-24 2013-10-29 Nano-Retina, Inc. Retinal prosthesis with efficient processing circuits
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
KR20150038038A (en) 2012-07-23 2015-04-08 프로테우스 디지털 헬스, 인코포레이티드 Techniques for manufacturing ingestible event markers comprising an ingestible component
EP2722071A1 (en) * 2012-10-16 2014-04-23 Sapiens Steering Brain Stimulation B.V. A probe, especially a probe for neural applications
KR101565013B1 (en) 2012-10-18 2015-11-02 프로테우스 디지털 헬스, 인코포레이티드 Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
WO2014099303A1 (en) 2012-12-21 2014-06-26 Exxonmobil Chemical Patents Inc. Bridged metallocene compounds, catalyst systems and processes for polymerization therewith
JP2016508529A (en) 2013-01-29 2016-03-22 プロテウス デジタル ヘルス, インコーポレイテッド Highly expandable polymer film and composition containing the same
WO2014138709A1 (en) 2013-03-08 2014-09-12 Oculeve, Inc. Devices and methods for treating dry eye in animals
US9351436B2 (en) 2013-03-08 2016-05-24 Cochlear Limited Stud bump bonding in implantable medical devices
WO2014165124A1 (en) 2013-03-12 2014-10-09 Oculeve, Inc. Implant delivery devices, systems, and methods
US9370417B2 (en) 2013-03-14 2016-06-21 Nano-Retina, Inc. Foveated retinal prosthesis
US9583458B2 (en) 2013-03-15 2017-02-28 The Charles Stark Draper Laboratory, Inc. Methods for bonding a hermetic module to an electrode array
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
NZ704579A (en) 2013-04-19 2018-10-26 Oculeve Inc Nasal stimulation devices and methods
JP2016523125A (en) 2013-05-30 2016-08-08 グラハム エイチ. クリーシー Local nervous stimulation
US11229789B2 (en) 2013-05-30 2022-01-25 Neurostim Oab, Inc. Neuro activator with controller
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
WO2015041944A1 (en) * 2013-09-17 2015-03-26 California Institute Of Technology Multi-layer packaging scheme for implant electronics
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US9474902B2 (en) 2013-12-31 2016-10-25 Nano Retina Ltd. Wearable apparatus for delivery of power to a retinal prosthesis
US9331791B2 (en) 2014-01-21 2016-05-03 Nano Retina Ltd. Transfer of power and data
EP3689338A1 (en) 2014-02-25 2020-08-05 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
AU2015292278B2 (en) 2014-07-25 2020-04-09 Oculeve, Inc. Stimulation patterns for treating dry eye
WO2016065215A1 (en) 2014-10-22 2016-04-28 Oculeve, Inc. Stimulation devices and methods for treating dry eye
CA2965363A1 (en) 2014-10-22 2016-04-28 Oculeve, Inc. Implantable nasal stimulator systems and methods
WO2016065211A1 (en) 2014-10-22 2016-04-28 Oculeve, Inc. Contact lens for increasing tear production
US11077301B2 (en) 2015-02-21 2021-08-03 NeurostimOAB, Inc. Topical nerve stimulator and sensor for bladder control
JP6214598B2 (en) * 2015-05-29 2017-10-18 ユニ・チャーム株式会社 Absorbent articles
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10918864B2 (en) 2016-05-02 2021-02-16 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
TWI728155B (en) 2016-07-22 2021-05-21 日商大塚製藥股份有限公司 Electromagnetic sensing and detection of ingestible event markers
CN109963499B (en) 2016-10-26 2022-02-25 大冢制药株式会社 Method for manufacturing capsules with ingestible event markers
RU2019118600A (en) 2016-12-02 2021-01-11 Окулив, Инк. APPARATUS AND METHOD FOR MAKING DRY EYE SYNDROME PREDICTION AND TREATMENT RECOMMENDATIONS
EP3706856A4 (en) 2017-11-07 2021-08-18 Neurostim Oab, Inc. Non-invasive nerve activator with adaptive circuit
CN112703210B (en) 2018-07-23 2022-10-28 埃克森美孚化学专利公司 Preparation of bimodal rubbers, thermoplastic vulcanizates, and articles made therefrom
EP3990100A4 (en) 2019-06-26 2023-07-19 Neurostim Technologies LLC Non-invasive nerve activator with adaptive circuit
CA3152451A1 (en) 2019-12-16 2021-06-24 Michael Bernard Druke Non-invasive nerve activator with boosted charge delivery
US20230085958A1 (en) 2021-09-10 2023-03-23 Greatbatch Ltd. A Ceramic Reinforced Metal Composite For Hermetic Bodies For Implantable Devices

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006286A (en) * 1986-03-31 1991-04-09 Amp Incorporated Polymeric electrical interconnection apparatus and method of use
US5468936A (en) * 1993-03-23 1995-11-21 Philip Morris Incorporated Heater having a multiple-layer ceramic substrate and method of fabrication
US5681757A (en) * 1996-04-29 1997-10-28 Microfab Technologies, Inc. Process for dispensing semiconductor die-bond adhesive using a printhead having a microjet array and the product produced by the process
US6057175A (en) * 1997-12-04 2000-05-02 Medtronic, Inc. Method of making encapsulated package
US6361716B1 (en) * 2000-07-20 2002-03-26 Dow Corning Corporation Silicone composition and electrically conductive silicone adhesive formed therefrom
US6399178B1 (en) * 1998-07-20 2002-06-04 Amerasia International Technology, Inc. Rigid adhesive underfill preform, as for a flip-chip device
US20030057470A1 (en) * 2001-09-12 2003-03-27 Murata Manufacturing Co., Ltd Circuit substrate
US6580031B2 (en) * 2000-03-14 2003-06-17 Amerasia International Technology, Inc. Method for making a flexible circuit interposer having high-aspect ratio conductors
US20030233134A1 (en) * 2002-04-11 2003-12-18 Greenberg Robert J. Biocompatible bonding method and electronics package suitable for implantation
US20040006264A1 (en) * 2001-11-20 2004-01-08 Mojarradi Mohammad M. Neural prosthetic micro system
US20040087128A1 (en) * 2000-10-24 2004-05-06 Neuhaus Herbert J Method and materials for printing particle-enhanced electrical contacts
US6985347B2 (en) * 2002-02-28 2006-01-10 Greatbatch-Sierra, Inc. EMI filter capacitors designed for direct body fluid exposure
US20060247734A1 (en) * 2005-04-28 2006-11-02 Greenberg Robert J Retinal prosthesis and method of manufacturing a retinal prosthesis

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1319774A (en) 1969-06-26 1973-06-06 Nat Res Dev Visual prosthetic device
US4614194A (en) * 1984-01-20 1986-09-30 Cordis Corporation Implantable pulse generator having a single printed circuit board for carrying integrated circuit chips thereon with chip carrier means
US4573481A (en) 1984-06-25 1986-03-04 Huntington Institute Of Applied Research Implantable electrode array
US4628933A (en) 1985-07-23 1986-12-16 Michelson Robin P Method and apparatus for visual prosthesis
US4837049A (en) 1986-06-17 1989-06-06 Alfred E. Mann Foundation For Scientific Research Method of making an electrode array
US5215088A (en) 1989-11-07 1993-06-01 The University Of Utah Three-dimensional electrode device
US5109844A (en) 1990-10-11 1992-05-05 Duke University Retinal microstimulation
KR0171438B1 (en) 1993-09-29 1999-10-15 모리시따 요오이찌 Method for mounting a semiconductor device on a circuit board, and a circuit board with a semiconductor device mounted thereon
US5750926A (en) * 1995-08-16 1998-05-12 Alfred E. Mann Foundation For Scientific Research Hermetically sealed electrical feedthrough for use with implantable electronic devices
US6043437A (en) * 1996-12-20 2000-03-28 Alfred E. Mann Foundation Alumina insulation for coating implantable components and other microminiature devices
US5876427A (en) * 1997-01-29 1999-03-02 Light Sciences Limited Partnership Compact flexible circuit configuration
DE19707046A1 (en) 1997-02-21 1998-08-27 Rolf Prof Dr Ing Eckmiller Learnable "Active Vision" implant encoder
US6458157B1 (en) 1997-08-04 2002-10-01 Suaning Gregg Joergen Retinal stimulator
US5935155A (en) 1998-03-13 1999-08-10 John Hopkins University, School Of Medicine Visual prosthesis and method of using same
US6617671B1 (en) * 1999-06-10 2003-09-09 Micron Technology, Inc. High density stackable and flexible substrate-based semiconductor device modules
EP1223612A4 (en) 2000-05-12 2005-06-29 Matsushita Electric Ind Co Ltd Semiconductor device mounting circuit board, method of producing the same, and method of producing mounting structure using the same
US6402526B1 (en) * 2000-11-03 2002-06-11 Delphi Technologies, Inc. Microelectronic contact assembly
US6653170B1 (en) * 2001-02-06 2003-11-25 Charles W. C. Lin Semiconductor chip assembly with elongated wire ball bonded to chip and electrolessly plated to support circuit
TW501384B (en) * 2001-03-27 2002-09-01 Hannstar Display Corp Monitoring device and method for tape automated bonding
AU2002257344B2 (en) * 2001-05-30 2006-05-25 Foster-Miller, Inc. Implantable devices having a liquid crystal polymer substrate
US6973225B2 (en) * 2001-09-24 2005-12-06 National Semiconductor Corporation Techniques for attaching rotated photonic devices to an optical sub-assembly in an optoelectronic package
WO2003061537A1 (en) * 2002-01-17 2003-07-31 Masachusetts Eye And Ear Infirmary Minimally invasive retinal prosthesis
US8660645B2 (en) * 2002-02-28 2014-02-25 Greatbatch Ltd. Electronic network components utilizing biocompatible conductive adhesives for direct body fluid exposure
JP2004107378A (en) 2002-09-13 2004-04-08 Three M Innovative Properties Co Multilayered ionic conductive adhesive and bioelectrode
US7483750B2 (en) 2003-03-21 2009-01-27 Second Sight Medical Products, Inc. Transretinal implant and method of implantation
JP2005295041A (en) 2004-03-31 2005-10-20 Kyocera Kinseki Corp Process for fabricating piezoelectric vibrator
US7068491B1 (en) * 2005-09-15 2006-06-27 Medtronic, Inc. Implantable co-fired electrical interconnect systems and devices and methods of fabrication therefor

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006286A (en) * 1986-03-31 1991-04-09 Amp Incorporated Polymeric electrical interconnection apparatus and method of use
US5468936A (en) * 1993-03-23 1995-11-21 Philip Morris Incorporated Heater having a multiple-layer ceramic substrate and method of fabrication
US5681757A (en) * 1996-04-29 1997-10-28 Microfab Technologies, Inc. Process for dispensing semiconductor die-bond adhesive using a printhead having a microjet array and the product produced by the process
US6057175A (en) * 1997-12-04 2000-05-02 Medtronic, Inc. Method of making encapsulated package
US6399178B1 (en) * 1998-07-20 2002-06-04 Amerasia International Technology, Inc. Rigid adhesive underfill preform, as for a flip-chip device
US6580031B2 (en) * 2000-03-14 2003-06-17 Amerasia International Technology, Inc. Method for making a flexible circuit interposer having high-aspect ratio conductors
US6361716B1 (en) * 2000-07-20 2002-03-26 Dow Corning Corporation Silicone composition and electrically conductive silicone adhesive formed therefrom
US20040087128A1 (en) * 2000-10-24 2004-05-06 Neuhaus Herbert J Method and materials for printing particle-enhanced electrical contacts
US20030057470A1 (en) * 2001-09-12 2003-03-27 Murata Manufacturing Co., Ltd Circuit substrate
US20040006264A1 (en) * 2001-11-20 2004-01-08 Mojarradi Mohammad M. Neural prosthetic micro system
US6985347B2 (en) * 2002-02-28 2006-01-10 Greatbatch-Sierra, Inc. EMI filter capacitors designed for direct body fluid exposure
US20030233134A1 (en) * 2002-04-11 2003-12-18 Greenberg Robert J. Biocompatible bonding method and electronics package suitable for implantation
US20070005112A1 (en) * 2002-04-11 2007-01-04 Greenberg Robert J Biocompatible bonding method and electronics package suitable for implantation
US20060247734A1 (en) * 2005-04-28 2006-11-02 Greenberg Robert J Retinal prosthesis and method of manufacturing a retinal prosthesis

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7868440B2 (en) * 2006-08-25 2011-01-11 Micron Technology, Inc. Packaged microdevices and methods for manufacturing packaged microdevices
US20080048316A1 (en) * 2006-08-25 2008-02-28 Micron Technology, Inc. Packaged microdevices and methods for manufacturing packaged microdevices
US8987885B2 (en) 2006-08-25 2015-03-24 Micron Technology, Inc. Packaged microdevices and methods for manufacturing packaged microdevices
US8354301B2 (en) 2006-08-25 2013-01-15 Micron Technology, Inc. Packaged microdevices and methods for manufacturing packaged microdevices
US8906748B2 (en) * 2009-06-29 2014-12-09 Hon Hai Precision Industry Co., Ltd. Method for packaging a semiconductor structure
US20120231585A1 (en) * 2009-06-29 2012-09-13 Hon Hai Precision Industry Co., Ltd. Method for packaging a semiconductor structure
US10525258B2 (en) 2009-08-05 2020-01-07 Stryker Corporation Implantable electrode array assembly including a carrier with packaged control modules
US9950154B2 (en) 2009-08-05 2018-04-24 Stryker Corporation Method of manufacturing an implantable electrode array by forming packages around the array control modules after the control modules are bonded to substrates
US9770582B2 (en) 2009-08-05 2017-09-26 Stryker Corporation Implantable electrode array assembly including a carrier with embedded control modules contained in packages, the packages extending outwardly so as to extend over the carrier
US20110089041A1 (en) * 2009-10-19 2011-04-21 Biomet Manufacturing Corp. Methods of depositing discrete hydroxyapatite regions on medical implants
US10046158B2 (en) * 2009-12-11 2018-08-14 Stryker Corporation Implantable electrode array assembly with an array substrate, electrodes and integrated circuits, the integrated circuits being attached to package substrates
WO2011072128A1 (en) * 2009-12-11 2011-06-16 Stryker Corporation Implantable electrode array assembly with electrodes that are integral with the asics that source/sink current to the electrodes
US10342971B2 (en) 2009-12-11 2019-07-09 Stryker Corporation Implantable electrode array assembly with an array substrate, electrodes and packaged integrated circuits
US20120330393A1 (en) * 2009-12-11 2012-12-27 John Janik Implantable electrode array assembly with an array subtrate, electrodes and integrated circuits, the integrated circuits being attached to package substrates
US10260142B2 (en) * 2010-03-30 2019-04-16 Wise S.R.L. Method for the production of functionalized elastomeric manufactured articles and manufactured articles thus obtained
US20130017367A1 (en) * 2010-03-30 2013-01-17 Wise S.R.L. Method for the production of functionalized elastomeric manufactured articles and manufactured articles thus obtained
AU2011245293B2 (en) * 2010-04-30 2014-06-19 Second Sight Medical Products, Inc. Improved biocompatible bonding method
WO2011137298A3 (en) * 2010-04-30 2011-12-22 Second Sight Medical Products,Inc. Improved biocompatible bonding method
US8386047B2 (en) 2010-07-15 2013-02-26 Advanced Bionics Implantable hermetic feedthrough
US8552311B2 (en) 2010-07-15 2013-10-08 Advanced Bionics Electrical feedthrough assembly
WO2012015756A3 (en) * 2010-07-29 2012-05-31 Proteus Biomedical, Inc. Hybrid housing for implantable medical device
WO2012015756A2 (en) * 2010-07-29 2012-02-02 Proteus Biomedical, Inc. Hybrid housing for implantable medical device
US20130223028A1 (en) * 2010-07-29 2013-08-29 Proteus Digital Health, Inc. Hybrid housing for implantable medical device
US9511216B2 (en) 2011-09-28 2016-12-06 Advanced Bionics Ag Modular biomedical implants
WO2013048396A1 (en) * 2011-09-28 2013-04-04 Advanced Bionics Ag Modular biomedical implants
US9802036B2 (en) 2013-01-11 2017-10-31 Retina Implant Ag Device for contacting and electrically stimulating biological tissue
WO2014108266A1 (en) * 2013-01-11 2014-07-17 Retina Implant Ag Device for the contacting and/or electrostimulation of biological tissue
NL2013213B1 (en) * 2014-07-18 2016-07-14 Sapiens Steering Brain Stimulation Bv An electrical connection assembly for a medical implant and a method of providing an electrical connection between a thin film and a connector for a medical implant.
US11116964B2 (en) 2016-11-07 2021-09-14 Micro-Leads, Inc. Multi-electrode array with unitary body
US12053628B2 (en) 2016-11-07 2024-08-06 Micro-Leads, Inc. Multi-electrode array with unitary body
WO2019036210A1 (en) * 2017-08-15 2019-02-21 Verily Life Sciences Llc Hybrid neurostimulation lead combining flexible circuit electrodes with lead body having bulk conductor
US11395924B2 (en) 2019-01-07 2022-07-26 Micro-Leads, Inc. Implantable devices with welded multi-contact electrodes and continuous conductive elements
EP3908360A4 (en) * 2019-01-07 2022-11-02 Micro-Leads, Inc. Implantable devices with welded multi-contact electrodes and continuous conductive elements

Also Published As

Publication number Publication date
WO2007106318A3 (en) 2007-12-21
US20080051848A1 (en) 2008-02-28
US20120185025A1 (en) 2012-07-19
US8285380B2 (en) 2012-10-09
US7835794B2 (en) 2010-11-16
US8644937B2 (en) 2014-02-04
US20130006340A1 (en) 2013-01-03
US20120022625A1 (en) 2012-01-26
US7645262B2 (en) 2010-01-12
WO2007106318A2 (en) 2007-09-20
US8165680B2 (en) 2012-04-24

Similar Documents

Publication Publication Date Title
US9849297B2 (en) Biocompatible bonding method and electronics package suitable for implantation
US7645262B2 (en) Biocompatible bonding method and electronics package suitable for implantation
US20120131794A1 (en) Biocompatible Bonding Method and Electronics Package Suitable for Implantation
US7846285B2 (en) Biocompatible electroplated interconnection bonding method and electronics package suitable for implantation
EP2563464B1 (en) Improved biocompatible bonding method
US9895529B2 (en) Device with flexible multilayer system for contacting or electrostimulation of living tissue cells or nerves
AU2011245293A1 (en) Improved biocompatible bonding method
US20200215335A1 (en) Implantable devices with welded multi-contact electrodes and continuous conductive elements
Patrick et al. Design of an implantable intracortical microelectrode system for brain-machine interfaces

Legal Events

Date Code Title Description
AS Assignment

Owner name: SECOND SIGHT MEDICAL PRODUCTS, INC., CALIFORNIA

Free format text: MERGER;ASSIGNOR:SECOND SIGHT, LLC;REEL/FRAME:018501/0839

Effective date: 20030715

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2553); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 12

AS Assignment

Owner name: CORTIGENT, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VIVANI MEDICAL, INC.;REEL/FRAME:062588/0132

Effective date: 20221228